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Phospholipid vesicles (Liposomes) for controlled release applications such as 
drug and gene delivery have attracted great interest.  However, lack of long term stability 
and low solute encapsulation efficiency limit the usage of liposomes in many areas.  In 
this thesis, charged surfactant vesicles that are formed spontaneously in mixtures of 
single-tailed surfactants are investigated as an alternative for liposomes in applications 
where improved long-term capture of charged organic molecules is desirable.  The 
system of interest is dilute solutions of cetyltrimethylammonium tosylate (CTAT) and 
sodium dodecylbenzenesulfonate (SDBS).   
It is shown that charged surfactant vesicles have a high efficiency for 
encapsulating oppositely charged probe molecules with extremely slow release rates. 
Several probe molecules, both anionic and cationic, were studied including the cancer 
chemotherapeutic drug doxorubicin (Dox).  All probe molecules were captured at high 
efficiency (ca. 20-70%) when the vesicle bilayer was of opposite charge from the probe 
molecule; when the charge of vesicle and probe molecule was the same, encapsulation 
was diminished (ca. 0-8%).  Strong electrostatic interaction between surfactant vesicles 
and charged molecules are responsible for the extremely high encapsulation efficiency.  
The vesicle/probe formulations are stable for weeks to months due to the inherent 
stability of these vesicles which form spontaneously and are believed to be equilibrium 
structures.  These properties allow surfactant vesicles to be used to selectively separate 
oppositely charged dye molecules, and this is demonstrated. 
 
Fluorescence correlation spectroscopy (FCS) was used to gain deeper 
understanding into the role of electrostatics in the capture of charged probe molecules by 
charged surfactant vesicles.  FCS measures the diffusion of fluorescent probe molecules 
in aqueous solutions at very low concentrations (10-9-10-8 M) and distinguishes between 
rapidly diffusing single molecules and slowly diffusing molecules that are adsorbed on a 
vesicle bilayer.  This method is sensitive enough to rapidly determine the fraction of 
probe molecules bound to the bilayer interface in a given sample.  Binding isotherms 
were constructed from FCS measurements in which a series of solutions were measured 
by holding the dye concentration constant while increasing the vesicle concentrations.  
The resulting isotherm yields a measure of binding energy.  Comparisons of binding 
 
energies show that probe/bilayer interactions are mainly governed by charge-charge 
interactions but may also depend on the size and structure of the surfactant counter ions. 
 
Our findings provide useful guidelines for implementing surfactant vesicles in 
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Chapter 1. Introduction and Overview 
 
This thesis describes recent work where vesicles formed from single-tailed 
surfactants are quantitatively evaluated for use in the capture and release of water soluble 
charged molecules.  Before describing this work it is important to have some knowledge 
of conventional vesicles that form from double-tailed, naturally-occurring phospholipid 
molecules.  Phospholipid vesicles and their weaknesses as drug delivery vehicles will be 
discussed before turning to surfactant vesicles.  For the purpose of this thesis, we will 
refer to vesicles formed from phospholipids as liposomes and vesicles formed from 
single-tailed surfactants as catanionic vesicles or simply surfactant vesicles. 
 
1.1.  Historical Overview and Description of Liposomes 
 
Liposomes are spherical bilayer shells that enclose an inner water pool, (see 
Figure 1.1.).  Liposomes were first reported by Bangham et al. in the mid-1960s.1,2  
Liposomes have since been investigated extensively as molecular “vessels” due to their 
hollow structure and ability to hold and release water soluble molecules.  Their versatility 
in terms of size, composition and surface charge make liposomes of particular interest as 
model systems for cell-membranes and they have been utilized in applications such as 




Figure 2.1. Liposomal structure. Liposomes are spherical shells formed from bilayers 
that occur when lipid molecules such as 1-Palmitoyl-2-oleoyl-sn-glycero-3- 
phosphocholine (POPC) self-assemble into lamellar structures. 
Liposomes were proposed as a drug delivery system in the 1970s to reduce the 
toxicity or increase the efficiency of drug molecules.3  In the l980s and early 1990s, 
several liposomal preparations entered the market. Today, the most widely used 
liposomal formulation from the pharmaceutical industry is DOXIL, and it was also the 
first liposomal anticancer drug licensed worldwide.4  DOXIL was used in the treatment of 
ovarian cancer, AIDS-related Kaposi’s sarcoma and multiple myeloma.  DOXIL is a 
reformulated version of the chemotherapeutic agent doxorubicin.  DOXIL consists of the 
active agent doxorubicin contained in a liposome coated with methoxypolyethylene 
glycol (MPEG).  This coating protects liposomes from detection and destruction by the 
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immune system resulting in an increased blood circulation time.  In the cosmetic industry, 
liposomal formulations have been used to encapsulate functional ingredients, reducing 
their epidermal permeation rate.  This helps to stabilize active ingredients to the 
outermost skin layers as desired for cosmetic products.  
  
A major drawback that has prevented wider use of liposomes is long term stability.  
Liposomes are formed by applying external mechanical forces such as sonication or 
extrusion to phospholipid bilayers.  Hence, liposomes are kinetically trapped structures 
and not in a thermodynamically stable state.  Over the time, liposomes tend to fuse or 
rupture and the molecules encapsulated inside are released during those processes. 
       
Another potential drawback of liposomes is that the encapsulation efficiency for 
drug delivery purposes is usually very low.  Encapsulation efficiency is generally defined 
as the percentage of the total amount of solute molecules that are held by the liposome 
when the preparation is first prepared.  The unencapsulated solute can be separated from 
the liposomes by size exclusion chromatography to determine the encapsulation 
efficiency.  Methods to achieve this are described in the next chapter.  Efforts to improve 
the performance of liposomes with respect to stability and drug-loading have been made 
by changing the compositions of the vesicles bilayer.  For instance, by adding cationic 
lipids to liposomes their ability to deliver DNA and act as transfection vectors was 
improved substantially.5-7  Also, pH-sensitive liposomes have been used to  enhance the 
cytoplasmic delivery of drug molecules.8  However these efforts require very complicated 
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and expensive preparation processes and do not necessarily improve the stability of 
liposomes. 
 
Finding a replacement for liposomes with higher encapsulation ability and longer 
shelf-life has motivated researchers to explore other drug delivery systems such as 
polymers 9, dendrimers,10 or hydrogels11.  Those systems also suffer drawbacks such as 
low encapsulation efficiency.  A promising alternative is the use of surfactant vesicles 
formed from aqueous mixtures of single-tailed common surfactants. 
 
1.2.  Surfactant Vesicles 
    
1.2.1.  Building Blocks and Classification  
 
 
The building blocks of surfactant vesicles are amphiphilic molecules or 
surfactants (“surface active agents”).  Generally surfactant molecules have a long single 
or double-tailed alkyl chain, covalently linked to a hydrophilic head group.  Based on the 
charges present in the hydrophilic head group, surfactant can be classified as (See 
Table1.1): 
1. Cationic, with the hydrophilic head group carrying a positive charge such as a tertiary 
amine. 
2. Anionic, with the hydrophilic head group bearing a negative charge, for instance a 
phosphate or sulfonate group. 
3. Zwitterionic, in which the molecule contains both a positive and a negative charge as 
in many phospholipid molecules (see Figure 1.1). 
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4. Nonionic, where the hydrophile has no charge, but derives its water solubility for 
highly polar group such as RC6H4(OC2H4)xOH (polyoxyethylenated alkylphenol) and 




Table 1.1. Examples of surfactant molecules. 
 
To date, several different types of surfactant vesicles have been discovered and 
classified.  When non-ionic surfactants such as polyglyceryl alkyl ethers are used to make 
vesicles, they are referred to as “Niosomes”.12,13   “Catanionic” vesicles are the topic of 
this research thesis and are made from simple mixtures of cationic and anionic surfactants 
in aqueous solution.  A feature of catanionic vesicles that is of particular importance to 
this work is the presence of a net charge on the bilayer due to a molar excess of either the 
cationic or anionic surfactant.  The work described herein focuses exclusively on 









































1.2.2.  Historical Overview 
 
 
        The initial study of surfactant vesicles started after Gebicki and Hicks reported that 
vesicles can spontaneously form from deprotanated unsaturated fatty acids (such as oleic 
acid) in 1973.14  Partially ionized acids play an important role in the formation and 
stability of such systems which is different from the formation mechanism of liposomes. 
Based on this discovery, many surfactant vesicle systems have been explored.15,16  The 
mechanism of formation of such vesicles also has been discussed.17-19  Properties of 
surfactant vesicles such as composition, vesicle size and phase behaviors have been well-
described in these studies.20  Of particular interest are surfactant vesicles that form 
spontaneously in mixtures of two single-tailed and oppositely charged surfactants. 
Spontaneous vesicle formation requires a molar excess of one surfactant and therefore 
catanionic vesicles always have a net charge.  Because they form spontaneously, they are 
commonly referred to as equilibrium vesicles.  Whether or not they are a truly 
equilibrium system is still under debate,21,22 but it is well-confirmed that catanionic 
vesicles are extremely stable and can exist over months or even years.23  Kaler and 
coworkers have studied several vesicle systems that form from common surfactants.  The 
low cost and simple methods for forming these types of vesicles make them extremely 
attractive for industrial applications. 
 
1.2.3.  Spontaneous Vesicle Formation  
 
When amphiphilic molecules such as surfactants, fatty acids or lipids dissolve in 
aqueous solution these molecules tend to aggregate into specific structures in order to 
shield the hydrophobic regions from water.  The dominant driving force governing self 
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assembly in water is the hydrophobic effect.  The “hydrophobic effect” refers to the 
reduction in the free energy ( aggG∆ ) that occurs when aggregates form thermodynamic 
stable states in water.  Some aggregates include spherical micelles, cylindrical micelles, 
and reverse micelles (see Table 1.2.).  The type of structure formed is strongly dependent 
on the geometry of the amphiphile and consequently its packing properties, which can be 
characterized by the packing parameter, P.  First defined by Israelachvili in 1976, the 
packing parameter is the ratio of the volume of the hydrophobic tail of the amphiphile, v, 
to the product of the chain length of the hydrophobic tail, l, and the cross-sectional area 






=  (1) 
The value of P, and the corresponding geometry of the amphiphile, can be used to 
predict which aggregate structure is formed by a particular amphiphile.26  Molecules with 
a value of P that is less than 1/3 (cone shaped) tend to form spherical micelles, while 
molecules with a P value between 1/3 and 1/2 (truncated cone) tend to form cylindrical, 
or rod-like, micelles (see Table 1.2 ).  If the P value is between 1/2 and 1 (cylindrical), 
then the molecules form curved bilayers which can assemble into vesicles (as P 
approaches 1, flat bilayers become predominant).  Conversely, a P value greater than 1 
means the geometry is that of an inverted cone, and the molecules, if they are in a 
hydrophobic environment, form reverse micelles (the hydrophobic tails point outward 
and the polar headgroups are on the inside of the micelle).  The relationship between 




Table 1.2. Aggregates of amphiphilic molecules.  Depending on the packing parameter of 
the amphiphile, and the corresponding geometry, various aggregate structures can form.  
In all cases (except reverse micelles) the hydrophobic regions are positioned so as to be 
shielded from the hydrophilic environment.  Vesicles enclose an aqueous compartment 
separate from the bulk solution.  Figure adapted from Ref. 24. 
    
 
  The very first report of spontaneously-formed surfactant vesicles was in 1989 by 
Kaler.23  Their system consisted of aqueous mixtures of cetyltrimethylammonium 
tosylate (CTAT) and sodium dodecylbenzenesulfonate (SDBS).  Both CTAT and SDBS 
are single tailed surfactants.  CTAT is a positive charged surfactant, which has a positive 
head group CTA+ associated with a tosylate counter ion.  While SDBS is a negative 









 Figure 1.2.   Structures of CTAT and SDBS. 
 
The ternary phase diagram of the CTAT/SDBS/Water system was constructed by 
Kaler, et al. in 1989.23  Figure 1.3. shows the water rich corner of this phase diagram.27  
Shown in Figure 1.3. is the water rich corner of this ternary phase  diagram23 at 25 oC and 
compositions are on a weight percent basis.  In this diagram, starting from CTAT-rich 
region (left hand side) are CTAT-rich rodlike micelles.  Next to it is a two phase region 
that includes liquid crystalline and an unresolved multiphase.  Vesicles are observed in 
compositions corresponding to the two lobes labeled V+ and V-.  The two-phase regions 
labeled III and shaded are V+ and CTAT-rich lamellar phase (La+) to the left of the 
equimolar line and V- and SDBS-rich lamellar phase (La-) on the right of the equimolar 
line. Region IV contains SDBS-rich micelles.  Precipitation occurs along the equimolar 
line.   
 
Vesicles are observed in compositions corresponding to the two lobes labeled V+ 
and V-.  The vesicles can be easily obtained by preparing solutions at these compositions 
and allowing them to equilibrate for about 48 h.  Under these conditions surfactant 
  
Cetyltrimethylammonium tosylate (CTAT)   




vesicles form spontaneously.  The fact that vesicles only form in mixtures where one 
surfactant is in excess will be important to the work described in this thesis.  Also, it 
should be noted that in equimolar solutions the surfactants actually precipitate.  When the 
CTAT concentration is greater than SDBS the vesicles are denoted as V+.  For the 










Figure 1.3.  Water-rich corner of the ternary phase diagram for the CTAT/SDBS system.  
Two blue lobes indicate the presence of vesicles.  The bottom axis of the phase diagram 
is weight ratio of surfactants and the side axes show total surfactant concentration. 
Adapted from ref. 27.  
 
In addition to the CTAT/SDBS system a number of other surfactant vesicles have 
been found that can be formed by simply mixing two oppositely charged single tailed 
surfactants together with water.20  The mechanism of formation is believed to be based on 
the formation of surfactant ion pairs for which the formation is favored by both 
electrostatic and hydrophobic interactions.  The geometry of an ion pair formed from two 
single tailed surfactants is an analog of a phospholipid molecule with a packing 

























I II III IV
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aggregate, i.e. bilayer.  But different from liposomes, surfactant vesicles always have an 
excess of one charged surfactant due to the molar excess of either cationic or anionic 
surfactant. Equal molar mixture of two oppositely charged surfactants causes phase 
separation.  It is thought that the excess surfactant helps to fluidize the vesicle bilayer.23   
 
A single tailed surfactant usually has a larger head group compared with its 
hydrophobic tail which gives P< 2
1 .  Hence, in most cases, surfactants form micelles 
spontaneously when mixed with water.  However, if two oppositely charged single tailed 
surfactants are mixed together, due to the electrostatic interaction, ion pairs form.  The 
average head group area of an ion pair is decreased by electrostatic attraction.  Therefore, 
it is smaller than the sum of the two single surfactant head groups.  Since, the average tail 
volume of an ion pair is the sum of two single tails, the P of such an ion pair is close to 
unity.  This allows bilayer structure to form from mixtures of two single tailed oppositely 
charged surfactants.  The formation of ion pairs describes why a bilayer forms 
spontaneously but does not account for the spontaneous bilayer curvature that is 
necessary to form an equilibrium vesicle. 
 
To understand how a catanionic vesicle forms spontaneously, a theoretical model 
used to describe the stability and formation of liposomes, can be utilized for surfactant 
vesicles.17 In 1973, Helfrich used curvature elastic energy, fc, to help explain vesicle 
stability.  In this model, the simplified bending energy per unit area for liposome is: 
                                           ( ) ( )[ ]222 ioc ccccKf −++=                            (1) 
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where K is bending modulus, oc and ic  are the two spontaneous curvatures of outer and 
inner monolayers given by the inverses of their radii.  The quantity c is the actual vesicle 
curvature.  For a single component system, oc  and ic are equal.  In this case, when c = 0 
or flat bilayer, the minimum cf  can be obtained.  This explains why the formation of 
lipid vesicles needs extra energy.   











Figure 1.4. a) The formation of ion pairs. b) The asymmetrical curvatures and 
inhomogeneous compositions of the inner and outer layers of surfactant vesicles. 
 
 
In a mixed system of two surfactants is possible for the two layers of the bilayer 
to have different composition, i.e. nonideal mixing.  This composition asymmetry effect 
must be considered.  Safran et al. gave a detailed calculation. 18,28  The total free energy 
is18  






















2 φεφ AKf                                                       (2) 
where φ  is the composition difference between two layers.  Bothε  and A are parameters 
determined by the volume fraction of one surfactant, interaction between two different 
surfactants and the curvature of vesicles.  The sign of ε  is negative for a planar bilayer 
with zero curvature and positive for vesicles.  In mixtures of surfactants where the 
surfactants tend to form micelles in water (both curvatures are negative), nonideal mixing 
in which more of the unpaired surfactants are present on the outer layer favors vesicle 
formation.  
 
Both surfactant geometry and mixing are of critical importance for spontaneous 
vesicle formation.  For these reasons, vesicles only form in the well defined regions of 
the phase diagram, as shown in Figure 1.3.  The asymmetric distribution of surfactants is 
crucial for determining the functions of surfactant vesicles in stability and encapsulation 
efficiency.  The details of which will be discussed in Chapter 5. 
 
1.2.4.  Advantages  
 
 
Some areas where surfactant vesicles differ from conventional liposomes are: 1) 
less expensive components, 2) simple preparation methods 3) vesicles can be readily 
prepared with either negatively or positively charged bilayers 4) surfactant vesicles are 




1.3.  Goals 
 
The features of surfactant vesicles reveal that they hold some promise as a 
potential replacement for liposomes in applications such as drug delivery.  The goal of 
the research presented in this thesis is to provide an initial exploration into this possibility 
by examining the ability of surfactant vesicles to encapsulate and release water soluble 
molecules.  Until now, there have been very few studies reported in this area.   In 1989, 
Kaler mentioned glucose encapsulation in CTAT/SDBS system, but did not give any 
quantitative results.23  Caillet et al. investigated the encapsulate of the small neutral 
molecules glucose and riboflavin in surfactant vesicles formed from 
cetyltrimethylammonium bromide (CTAB) and sodium octyl sulfate (SOS).29  They 
achieved an encapsulation efficiency of about ~1%, for glucose  and 0.4% for riboflavin.  
Caillet also attempted to encapsulate the anionic dye carboxyfluorescein (CF) but 
observed no encapsulation.29  In their studies it appears that the presence of CF inhibited 
vesicle formation due to its high concentration (50 mM).   Results reported in this thesis 
show that the original work by Caillet is misleading and that ionic molecules can in fact 
be encapsulated with high efficiency.  The work reported in this thesis is the first to show 
that catanionic vesicles can be used as highly-efficient and long-term storage media for 
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Chapter 2.  Materials and Experimental Procedures 
 
 
2.1.  Materials  
 
 







Name Abbreviation Source 
5-(and-6)-carboxyfluorescein CF Invitrogen (USA) 
Cetyltrimethylammonium bromide CTAB Sigma Aldrich 
(USA) 
Cetyltrimethylammonium tosylate CTAT Sigma Aldrich 
(USA) 
Doxorubicin hydrochloride Dox Fluka (Germany) 
Egg yolk phosphatidylcholine EYPC Avanti Polar 
Lipids, Inc. (USA) 
Lucifer yellow LY Invitrogen (USA) 
Rhodamine 6G R6G Invitrogen (USA) 
Sephadex G50 Sephadex G50 Amersham 
Pharmacia Biotech 
(USA) 
Sterile solution of sodium chloride Saline CVS (USA) 
Sodium dodecylbenzenesulfonate SDBS Tokyo Chemical 
Industry (TCI) 
(USA) 
Sodium chloride  NaCl J.T. Baker (USA) 
Sulforhodamine 101 SR101 Invitrogen(USA) 
Triton X-100 Triton X-100 Fisher Scientific 
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 Deionized water was used in bulk experiments that included encapsulation 
efficiency studies, long term release experiments or dye separations.  In FCS experiments, 
ultrapure water from a Milli-Q water purification system (Millipore, USA) was used 
throughout.  Organic solvents such methanol and acetone were used in either histological 
or HPLC grade. 
 
 
2.2.  Experimental Procedures 
 
 
2.2.1.  Liposome Preparation 
 
 EYPC was purchased from Avanti Polar Lipids, Inc. and used without further 
purification. The mechanism of liposome formation is described as following.  
Chloroform was evaporated from solutions of pure EYPC (13.2 mM) using a gentle 
stream of nitrogen before being placed overnight in a vacuum desiccator to remove all 
organic solvent. The resulting films were hydrated with 1 mL of highly purified water. 
Disruption of the muiltilamellar aggregates was achieved by five freeze-thaw cycles by 
immersion in liquid nitrogen. Large unilamellar vesicles (LUV) (150 nm in diameter) 
were formed by extruding 13 times using a polycarbonate membrane with 100 nm pore 
size (Avanti Polar Lipids). Vesicle samples were purified using gel permeation 
chromatography (Sephadex G50, medium mesh, Amersham Pharmacia Biotech).  
 
2.2.2.  Surfactant Vesicle Preparation 
 
 
 All surfactant vesicles samples were prepared at a total surfactant concentration of 
1 wt.%.  The surfactants were weighed and mixed with deionized water by gentle stirring, 
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and then allowed to equilibrate at room temperature for at least 72 h.1  Following 
equilibration, the samples were passed through a 25 mm syringe filter (0.45 µm mesh) to 
remove impurities. Vesicle formation was confirmed by dynamic light scattering 
measurement to give the average sizes.  Vesicle samples were prepared at two different 
surfactant compositions, 70:30 and 30:70 w/w CTAT to SDBS, which are denoted as V+ 
and V–, respectively.  V+ refers to the excess positive charge on the vesicle bilayers when 
there is an excess of CTAT.  The average size of bare V+ or V- sample is 81 ± 13 nm and 
98 ± 6 nm, respectively. In 70:30 V+ samples, the concentrations of CTAT and SDBS are 
15.4 mM and 8.6 mM, respectively.  This corresponds to 6.8 mM excess CTAT, or a 1.8 
fold molar excess of cations.  Likewise, V– refers to vesicles with a net negative charge 
due to a 13.5 mM excess of SDBS (the samples contain 6.6 mM CTAT and 20.1 mM 
SDBS), or a 3.0 fold molar excess of anions.  
 
2.2.3. Size Exclusion Chromatography (SEC) 
 
 
Size exclusion chromatography (SEC) is a technique used to separate 
macromolecules according to their hydrodynamic volumes (sizes).  Small particles are 
entrapped in the porous medium and take a longer path and more time in comparison to 
large particles which never enter into the pores.  The size of surfactant vesicles (r>50 nm) 
is much larger than free dyes (r<1 nm), so when an appropriate porous medium is 
selected, SEC can be used to separate these two distinguishable species.  
 
The separation is performed in an ordinary glass chromatography column with a 
frit and is packed with very small porous polymer beads designed to have pores of 
different sizes.  If the packing material is a gel, this technique is called gel-filtration 
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chromatography (GFC).  Samples are loaded together with an elution buffer.  Different 
fractions of the filtered solution can be collected.  Subsequently, detection techniques 
such as UV-vis absorption spectroscopy (UV-vis), fluorescence spectroscopy and 
dynamic light scattering (DLS) can be applied to those fractions in order to analyze 
molecular absorption, fluorescence and particle sizes.  The apparatus and illustration for 









2.2.3.1. Determination of Apparent Encapsulation Efficiency by SEC 
 
 After vesicles are formed, they should be separated from the probe molecules that 
are not encapsulated and are free in solution.  Therefore, the fraction of probe molecules 
that have been captured by the vesicles is determined.    
  In our experiment, a 2 x 25 cm column packed with Sephadex G50 resin 
(medium mesh, Amersham Biosciences) was used. During elution, vesicle solutions 
divided into two clear bands, one containing the dye-bearing vesicles and the other 
consisting of free dye.  The apparent encapsulation efficiency (ε) was determined by 
measuring the amount of encapsulated dye relative to the total initial amount, using UV-
vis absorption (Hitachi U-3010 Spectrometer). It is thus defined as:  





ε =       (1) 
where V and C are volume and concentration and i denotes initial values taken from the 
original preparation and f denotes values taken from the leading band in the SEC column. 
To avoid artifacts in UV-vis spectroscopy from light scattering or from dye aggregation 
inside the vesicles, the absorbance of the encapsulated dye was determined after first 
disrupting the vesicle membranes by the addition of Triton X-100 surfactant. Since ε 
reflects contributions from a probe dye molecule that is both encapsulated in the water 
pool of the vesicle and electrostatically adsorbed on the bilayers of the vesicle sample. 
 
In addition to conventional SEC, quick spin columns proved to also be effective 
tools for rapidly analyzing the encapsulation of a vesicle sample.   Quick spin columns 
are small columns that fit into an ordinary centrifuge and allow centrifugal force to be 
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used to accelerate elution.  The columns and centrifuge for this work is shown in     
Figure 2.2.  Quick Spin columns contain gel filtration media that allow large molecules  
(e. g, vesicles) to pass through quickly while retaining small molecules (e. g. free dyes). 
The quick and clean separation is achieved by using centrifugation.  In this work, quick 
spin columns were used in long term experiments that determined the release rates over 
the course of weeks in order to determine how long catanionic vesicles retain solutes after 
an initial separation from free dye. 
 
Figure 2.2. Quick spin column and Minispin Centrifuge. 
 
To evaluate long term release profiles for dye-bearing vesicles the following 
procedure was used.  First, the initial vesicle-solute mixture was purified using SEC (as 
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described above) to remove the free, un-encapsulated solute.  The sample was then 
checked for release of solute from the vesicles over the course of several weeks.  For this 
purpose, quick-spin columns pre-packed with Sephadex G50 (fine) were used (Roche 
Applied Science, USA, additional beads for repacking the columns from Sigma).  On a 
specific day, a 100 µL aliquot was run through a quick-spin column by centrifugation 
(Minispin, Eppendorf, USA) at 3000 rpm for 15 s, and the eluted fraction was evaluated 
using UV-vis spectroscopy.  Any solute that had been released from the vesicles was 
retained by the quick-spin column.  The amount of solute eluted by the column 
corresponded to the solute still encapsulated by the vesicles.  The UV-vis absorption 
value for the eluted sample was divided by the corresponding value obtained on day zero 
(immediately after SEC) to yield the fraction of solute that remained encapsulated in the 
vesicles.  The above procedure was repeated at various times to create a release curve 
(i.e., encapsulated solute vs. time elapsed, as shown in Chapter 4, Figure 4.3.).   
 
2.2.4.  Vesicle Characterization  
 
 
2.2.4.1.  Dynamic Light Scattering (DLS) 
 
 
Dynamic light scattering (DLS) is a well established technique for measuring 
particle size over the size range from a few nanometers to a few microns.2,3  The principle 
of dynamic light scattering is described below. 
When a laser beam passes through an aqueous solution with suspended particles, 
the beam scatters from those particles in all directions, resulting in a scattering-angle-
dependent intensity pattern. If the particles are undergoing Brownian motion, the 
intensity pattern also fluctuates randomly.  Given that the particle sizes are on the order 
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of the wavelength of the incident light, the intensity and angular dependence of the 
scattered light can be used to characterize the particles size of scattering materials.  The 
scattered light is recorded as temporal fluctuations of intensities.  Correlation of the 
fluctuations provides dynamical properties of molecules.  Hence, the size distribution and 
diffusion characteristic of the molecules can be resolved. 
 
Figure 2.3. Schematic of dynamic light scattering. 
 
The setup of dynamic light scattering is shown in the Figure 2.3.  When incident 
light impinges on particles in solution, the scattered light is recorded by the detector 
which has been set at a certain angle from the direction of the incident light.  The 
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scattering light intensity is ( ) ( )trEtrEtrI sss ,(,(),( *∗∝ , where ( )trE s ,(
 
is the electric 
field of the scattering light.  Therefore, the light intensity is proportional to the electric 
field squared.  The scattered temporal fluctuation intensities can be autocorrelated as 
below: 
                                                 ( ) ( ) ( )ττ +•= tItIG                                                       (2) 
Furthermore, the autocorrelation function )(τG  can be expressed as τβτ Γ−+= 2)( ebG  , 
when the solution is sufficiently dilute to satisfy the assumption thayt there are no 
interactions between particles.  In this form of the autocorrelation function, b  is the 
baseline of the correlation function at infinite delay, β is the correlation function 
amplitude at zero decay, and Γ  is the decay rate. 
 
Figure 2.4. Illustration of wave vectors of incident and scattered light. 
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Among the above factors,    
                                         2Dq=Γ                                                                       (3) 
which links the autocorrelation function with the size, diffusion constant and size 
distribution of the particles in solution.  q, the wave vector difference between the 





q = , where n denotes 
the refractive index of solvent, λ  is the wavelength of incident light and θ  is the angle 
between the incident light and detector.  D in equation 3, is the diffusion constant for the 
particles of interest.  Since the random diffusion can be described by Brownian motion, 





= , where k 
is Boltzmann's constant, T is the temperature in K, η is the solvent viscosity and rh is the 
hydrodynamic radius of a diffusing sphere.  
 
In this work a Photocor-FC instrument was utilized to determine the size of 
surfactant vesicles before and after SEC.  The light source was a 5 mW laser at 633 nm 
and the scattering angle was 90°.  A logarithmic correlator was used to obtain the 
autocorrelation function, which was analyzed by the method of cumulants4 to yield a 
diffusion coefficient.  The apparent hydrodynamic size of the vesicles was obtained from 
the diffusion coefficient through the Stokes-Einstein relationship.  The intensity (total 








We exploit the self-quenching behavior of CF to monitor dye release from 
vesicles.  The following experimental protocol was used and is similar to that in an earlier 
study,5 except for changes made to allow the calculation of the fraction of dye released 
over  long periods (weeks).  Samples were checked on a specific day by placing a fixed 
aliquot (1.5 mL) into a 1 cm cuvette and monitoring fluorescence at 520 nm while 
exciting at 490 nm using a Spex Fluorolog-3 spectrometer ( Horiba Jobin Yvon, in USA).  
The intensity was monitored for several minutes to establish the baseline fluorescence 
intensity, which contains a contribution from both free and encapsulated dyes.  After the 
baseline was established, 100 µL of 10% (w/w) aqueous Triton X-100 was added to 
disrupt the vesicles.  Vesicle disruption results in the release of all dye molecules into 
solution and a concomitant increase in fluorescence (see Figure 3.1 in Chapter 3).  To 
monitor long-term leakage rates, the fraction of dye released as a function of time, R(t), 
was calculated for a given day.  This quantity measures the fraction of encapsulation on 
Day t relative to the initial value on Day 0:   





















oxx  (4) 
where F(initial) and F(final) are the fluorescence intensities before and after adding the 
Triton X-100.  This approach allows the direct determination of the proportion of the dye 






2.2.5. Fluorescence Correlation Spectroscopy (FCS) 
 
 Fluorescence correlation spectroscopy (FCS)6-8 is a correlation analysis of 
fluctuations of the fluorescence intensity arising from a dilute solution of fluorophores. 
An interesting application is the study of molecular interactions in solution.  In this 
application, the random motion of fluorescently labeled molecules inside a defined 
volume element excited by a focused laser beam is observed.  The fluorescence 
intensities fluctuate because of  Brownian motion of the particles.  These fluctuations 
provide information on the diffusion time of a fluorophore through the observation 
volume and this, in turn, depends directly dependent on the particle size.  Any change in 
the fluorophores diffusion time, e.g. as a result of an interaction with other molecules, is 
readily detected.  Hence, FCS is an ideal technique for the study of thermodynamic and 
kinetic features of molecular interactions in solution. 
 
The fluctuating fluorescence signal is analyzed by autocorrelation analysis.  The 
autocorrelation function is a mathematical method used to extract information such as 
amplitude and frequency of correlated fluctuations from data that may appear to consist 
of random fluctuations.  Defining the fluctuation in the measured temporal fluorescence 
of probe molecules )(tF  from the average value )(tF  
                             )()()( tFtFtF −=δ                                                               (5) 
The normalized autocorrelation function )(τG  of temporal fluctuations in the 
measured fluorescence )(tF is given by:7  
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τ                             (6)                                
where )( τ+tF is the same temporal fluorescence as )(tF , but with time lagτ . 
 
 
Further, the autocorrelation function can be related to diffusion of multiple 
species in solution by below derived equations: 9,10 
 
                                                                                                                                           (7) 
 
 
                                                                                                                                           (8) 
 
where iD  is the diffusion coefficient of the 
th
i  component in the system, ω and z are the 
beam width in the radial and axial direction at laser focal volume and iA denotes the 
fraction of the thi  species among total species with diffusion coefficient iD .  ∑ =
i
iA 1 .  gi 












































Figure 2.5. Cartoon of method for measuring the bound fraction of probe molecules in a 
vesicle solution. Fast decay corresponds to free probe molecules with small size. Slow 
decay arises from fluorophores bound to vesicles.  In solutions where both free and 
vesicle-bound dye is present the autocorrelation decay is a superposition of the two pure 
decays as described by equation 7.   
 
The autocorrelation decay obtained from solutions in which probe molecules are 
partially bound to vesicles is the superposition of diffusion of free probe molecules and 
vesicles.   Therefore fitting such a curve to equation 7 allows one to determine the 
fraction of bound molecules.11   Binding isotherms of probe molecules to vesicle bilayers 
can be constructed by varying concentrations of vesicles and hence the binding free 






Figure 2.6.  Schematic of scanning confocal fluorescence microscope. 
The FCS experiments were performed with an inverted fluorescence microscope 
from Carl Zeiss.  The sample was excited by an argon ion laser (usually 488 or 514 nm) 
or a He-Ne laser (543 nm).  A Zeiss Neofluar oil immersion objective (100x, N.A.=1.34) 
was used.  Separation of scattered excitation light from the collected emission was 
achieved by a Raman notch filter and/or long pass filter.  The intensity fluctuations were 
detected by avalanche photodiodes (APDs), and processed with the NI board.  The 
measurement was performed in the solution.  The data were collected and analyzed by 





2.2.6.  Time Tagged Method 
 
 
 As described in the previous section, FCS is a powerful technique to measure 
fluorophores diffusion in dilute solutions (~ nM).  FCS data are a series of temporal 
fluorescence intensity fluctuations.  Detectors, such as a photomultiplier tubes (PMT) or 
avalanche photodiode (APD), are used to detect photons, emitted when fluorophores 
diffuse in and out of a tiny laser focal volume (~1 fL) producing intensity fluctuations.  
The conventional method to collect FCS data is to record all temporal fluorescence 
fluctuations.  For example, when acquiring photon intensities with a temporal resolution 
of 1 µs, there are 106 intensity values recorded in 1 s.  While typically the count rate of an 
FCS measurement is only between 103 and 105 due to the low concentration of 
fluorophores.  Therefore, most intensity values for the majority of the time points in this 
method are zeros.  The redundant zeros which are stored in FCS data is the main 
drawback of this method, leading to a huge file size and making it inconvenient to move, 
store and analyze.  The detector response time limits the sampling time for FCS 
measurements.  For example, the APD (SPCM-AQR-15, Perkin Elmer) used in this study 
has a dead time 50 ns.  Hence, it is desirable to read the detector with a time resolution 
comparable to 50 ns.  In our studies we employ time-tagged analysis with 12.5 ns 
sampling time.  This method allows us to assign a time tag, which corresponds to the 
arrival time, to every detected photon.  
 
 The time-tagged method for FCS overcomes the shortcomings from the 
conventional method.  “Time tagged” concept originates from time-correlated single 
photon counting (TCSPC) which is used in not only fluorescence intensities but also 
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fluorescence lifetime measurement by applying a pulsed laser excitation, correlating the 
photon detection times on a nanosecond timescale and obtaining the time delay between 
the excitation and detection.12,13 The time-tagged method is a histogram method and 
records data only when actual photon events are detected.  This method combined with 
FCS measurement was proposed for improving the signal to noise ratio of FCS 
measurement 14,15 initially.  The time-tagged method for acquiring FCS data was used for 
studying the binding process of ionic organic molecules on charged surfactant vesicle 
bilayers due to the electrostatic interaction (Details in Chapter 5). 
  
 Time tagged method counts the elapsed time between photons arriving at a 
detector and stores this elapsed time tagged with 12.5 ns time resolution in time-tagged 
format.  From the lags between the photons, diffusion characters of fluorophores in 
solution can be obtained by constructed correlation function.  This method allows only 


















Figure 2.7.  Schematic of time tagged method. 
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 To collect time tagged data, a very sensitive photon detector, avalanche photon 
diodes (APD) and a set of timer and counter circuits are required. The schematic of 


















Figure 2.8.  Schematic of experimental setup of time tagged method. 
 
 
 A timer counter board PCI-6602 (National Instruments) was used to accomplish 
this acquisition.  The timer generates a continuous square wave at a frequency of 80 MHz 
which corresponds to 12.5 ns between pulses.  This timer is connected to an independent 
counter; the frequency is measured by this counter.  The APD is connected to the counter 
as a gate. Photon events arriving at the APD act as the gating events for the counter.  For 
example, when the first photon hits the APD it sends out a signal to the counter.  The 
counter starts to counter the number of frequencies from the timer.  When next photon is 
detected, the counter records the number of the 80 MHz pulses from the timer that have 
occurred since it began counting.  It converts that value to a total time, stores it and starts 













counts which can be converted into time.  Each value in the file corresponds to the 
number of 80 MHz pulses that took place since the last value was written, that is, the time 
between two subsequent photons being detected.  Hence, time-tagged data are obtained 
and an autocorrelation curve can be constructed to conduct further analysis. 
 
 The algorithm to convert time-tagged data to a correlation curve is described as 
follows.  As in the traditional FCS technique it is necessary to track the temporal 
correlation of each photon with all those that follow it.  When analyzing the time-tagged 
data one begins by examining the time difference between the first two photons which 
corresponds to the first number in the file.  Its value is sorted into a histogram as one pair 
of photons that occurred with a temporal separation of x.  The next photon is then 
considered relative to the first by adding the time between photon 2 and 3 (value 2 in the 
file) on to the previous value and sorting that into the histogram.  This process is iterated 
through until the time difference between the very first photon and the final one has been 
sorted into the histogram.  Then the second photon is considered and the time different 
between it and all the others are sorted into the histogram.  This process continues until 
the temporal difference between each pair of photons in the data set has been sorted into 
the histogram.  Then the program is terminated and the resulting histogram is the 
correlation curve which can be fit to obtain values for diffusion. 
 
. Correlation curves constructed by time tagged method of a real measurement of 
CF diffusion with different concentrations are shown in the Figure 2.9.  The first point of 
correlation curve is reversely proportional to the concentration of sample concentration in 
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theory.  And shown in the Figure 2.9, the first point in the three curves is corresponding 
to the CF concentration in the solution.  Time-tagged method is applicable and accurate 
in acquiring FCS data in this study.  
 
 
Figure 2.9. Autocorrelation decays for the samples containing the dye CF in water at 
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Chapter 3. Highly Efficient Capture and Long-Term Encapsulation of 
Dye by Catanionic Surfactant Vesicles 
Langmuir, 22 (15), 6461 -6464, 2006 
Xiang Wang, Emily J. Danoff, Nikolai A. Sinkov, Jae-Ho Lee,  
Srinivasa R. Raghavan, and Douglas S. English 
 
 
3.1.  Introduction 
 
The development of vesicles and liposomes for controlled release applications 
(e.g., in drug delivery, agrochemicals, or cosmetics) is a technological objective of great 
interest.  An important challenge in this area is the stability and shelf life of vesicles 
bearing drugs or other molecules.  Conventional phospholipid vesicles formed by 
sonication or extrusion are kinetically-trapped nonequilibrium structures.  Over time, 
these vesicles tend to fuse or rupture to form lamellar phases, and in the process, their 
contents are likely to be released.  Improvements in vesicle stability and encapsulation 
properties can be achieved by changing bilayer composition1-3 or by using micron-sized 
vesicles.4  
 
A simple, attractive alternative to phospholipid vesicles in some applications may 
be offered by surfactant vesicles, formed by mixing single-tailed cationic and anionic 
surfactants.  The existence of such “catanionic” vesicles has been known for over fifteen 
years.5  These vesicles are spontaneously generated when the individual surfactants are 
mixed with water in the right proportion.  Vesicle formation is thus quicker and easier 
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compared to phospholipid vesicles, since extrusion or sonication steps are not required. 
Furthermore, the required materials are common surfactants that are cheaper than purified 
or synthetic phospholipids.  Catanionic vesicles also tend to be stable for very long 
periods of time.  Whether these vesicles are truly equilibrium structures is still the subject 
of some debate.6,7   
 
For application of catanionic vesicles as storage and delivery agents of small 
molecules, the critical issue is their ability to encapsulate molecules.  In particular, a key 
unanswered question is how do catanionic surfactant vesicles compare to conventional 
phospholipid vesicles with regard to encapsulation efficiency and membrane permeability? 
Despite the extensive literature on catanionic vesicles, there is surprisingly little 
information on their encapsulating abilities or the permeability of their bilayers.  The few 
studies that have explored encapsulation with well-characterized catanionic vesicles 
focused principally on the entrapment of glucose.8-10  Another study by Zhao and co-
workers11 quantified the trapping efficiency of catanionic vesicles for a bromophenol 
blue dye, but did not study the membrane permeability or long-term stability.  In short, 
the ability of catanionic vesicles to entrap and encapsulate solutes, especially ionic 
molecules, remains large untested.12   
 
3.2.  Materials and Methods 
 
Here we report preliminary results from our studies on the encapsulation and 
subsequent release of a model ionic solute from catanionic vesicles.  We have chosen 
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carboxyfluorescein (CF) as our model solute.  CF is a widely used probe for vesicle 
encapsulation due to its ability to undergo efficient self-quenching of fluorescence at 
millimolar concentrations.  For example, when 60 mM CF is entrapped in vesicles, its 
fluorescence intensity is reduced by 60-80%, but as the dye is released from the vesicle, 
and thus diluted by the surrounding buffer, its fluorescence intensity increases.13,14  We 
employ this self-quenching phenomenon to monitor the release of entrapped CF from 
catanionic vesicles as well as the trapping efficiency of these vesicles.  The catanionic 
vesicles used here are from the well-known CTAT/SDBS system, which is a mixture of 
the single-tailed cationic surfactant, cetyltrimethylammonium tosylate (CTAT) and the 
single-tailed anionic surfactant, sodium dodecylbenzenesulfonate (SDBS). For 
comparison, we conduct similar encapsulation experiments with phospholipid vesicles 
formed from egg yolk phosphatidylcholine (EYPC).  The key result that we report in this 
work is that the catanionic vesicles are able to sequester CF more efficiently and for 
much longer periods of time than the phospholipid vesicles.  We use the term sequester to 
refer to dye that is either captured in the inner water pool of the vesicle or adsorbed to the 
bilayer since both modes of sequestration are observed here.  Our results, though limited 
in scope, demonstrate the possibility of catanionic vesicles as an extremely efficient 
alternative for long-term sequestering of small molecules.   
 
3.3.  Results 
 




  We studied the apparent encapsulation efficiency of CF in catanionic vesicles at 
two different CTAT/SDBS compositions, which are pinpointed in the phase diagram 
(Figure 3.1).9,15  The first sample falls in the CTAT-rich vesicle lobe and consists of 1 
wt.% total surfactant with a 7:3 w/w of CTAT to SDBS.  The vesicles in this case are 
denoted by V+ since they have a molar excess of the cationic surfactant.  The second 
sample falls in the SDBS-rich vesicle lobe and it is a 3:7 w/w mixture of CTAT to SDBS 
at 1 wt.% total surfactant. These vesicles are denoted by V–.   
 
Separation of free dye from CF bearing vesicles was achieved by size exclusion 
chromatography (SEC), as described in Chapter 2.  When encapsulation was achieved, 
two bands were well-resolved on the column and were visible with the naked eye or by 
viewing with a UV lamp.  The leading band contained vesicles and the second band 
contained the free dye. DLS experiments were used to confirm these assignments.  The 
DLS results from the leading band always gave values for hydrodynamic radius and total 
scattering intensity that were consistent with the presence of vesicles.  Initial V+ samples, 
prior to SEC, were found to have an average radius of 76 ± 5 nm, which was constant 
throughout the dilute surfactant range of 1.0% to 0.004% total surfactant concentration.  
This is consistent with the phase diagram in Figure 3.1.  V+ samples were also studied 















Figure 3.1. Phase diagram of CTAT/SDBS showing the dilute (water-rich) corner. 
Vesicles are present in the two lobes, denoted by V+ and V-. One composition in each 
lobe is used in this study and these compositions are indicated by the hollow circles.  
Adapted from ref. 15. 
 
 Apparent Encapsulation Efficiency, ε Adsorption 
EYPC 1.6± 0.2% 0.40± 0.08% 
V+ 21± 2% 16± 4% 
 
 
Table 3.1.  Apparent encapsulation efficiency and dye adsorption for CF on both EYPC 
vesicles and V+.  The apparent encapsulation efficiency reflects contributions from dyes 
that are adsorbed to the bilayer or captured in the inner water pool.  Therefore the actual 
encapsulation efficiency for dye in the V+ water pool is ca. 5%. 
 
In Table 3.1, we report the apparent encapsulation efficiency, ε, for CF in V+ and 
EYPC vesicle preparations.  The apparent encapsulation efficiency is calculated using the 
method described in the supporting information.  The value of ε gives percentage of dye 
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interactions between the solute and the vesicle wall, ε  is a measure of the aqueous 
volume enclosed by the vesicles relative to the total solution volume. 
 
For EYPC vesicles, ε is ca. 1.6%, in agreement with literature values.16  In 
comparison, the total enclosed volume of EYPC vesicles calculated from their average 
DLS radius is about 6%.  However, it should be noted that some leakage and rupture of 
the vesicles is likely to occur during the SEC process, which can explain the difference 
between these values.  Considering next the encapsulation efficiency for the catanionic 
V+ vesicles, we note from Table 3.1 that their ε is ca. 21%, which is extremely large 
compared to the EYPC lipid vesicles.  Dye encapsulation was evaluated using 1 mM CF 
since it was found that CF concentrations above 5 mM inhibited vesicle formation.  
Experiments to measure ε for V– samples were highly irreproducible, yielding ranges 
from 0 to 3% with no apparent dependence on any governable variables.  Given that the 
total concentration of surfactant is the same for both V+ and V– samples, the differences 
in the value and reliability of ε is unexpected from simple predictions based on enclosed 
volume.  The large and highly reproducible value of ε for the V+ samples is likely due to 
strong, specific interactions between the V+ bilayer and the anionic CF dye.  If this 
assertion is correct, one might expect a measurable value for ε even when the dye is 
added after vesicle formation due to strong interactions of CF with the outer leaflet of the 
V+ bilayer. 
 
To test whether adsorption of CF to the vesicle bilayer was significant, we 
conducted measurements in which the dye was added to the vesicle solution after  
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vesicles were formed.  These experiments were done with both EYPC and V+ vesicles, 
and in each case the vesicles were then separated on the SEC column and the amount of 
adsorbed dye was calculated.  The results in Table 3.1 show that only 0.4% of the dye 
was adsorbed on the EYPC vesicles, indicating that nonspecific interactions of the dye 
with the lipid bilayer were weak.  On the other hand, for the V+ samples, about 16% of 
the dye was adsorbed, which is comparable with the encapsulation efficiencies measured 
earlier.  Thus, binding of the anionic CF to the V+ bilayer contributes significantly to the 
amount of sequestered dye.  Since adsorption accounts for as much as 75% of the 
captured dye we have referred to ε  as the apparent encapsulation efficiency.  We 
hypothesize that adsorption occurs via direct, electrostatic interaction between the anionic 
dye and the excess cationic surfactant in the V+ bilayer.  Electrostatic interactions 
between charged surfactant vesicles and polyanions in solution have been observed,17 and 
Karukstis et al. have reported favorable dye-bilayer interactions in which association was 
observed to increase with surface charge.18  Our findings are significant because they 
illustrate that excess charge in the bilayer effectively increases the loading capacity of the 
vesicles.  To our knowledge this is a property of the catanionic surfactant vesicles that 
has not previously been reported.  
 
3.3.2.  Long-Term Dye Release 
 
We now consider the question of how long the encapsulated fraction remains in 
the V+ vesicle interior compared to encapsulation by EYPC vesicles.  As time progresses, 
we expect the encapsulated dye to leak through the vesicle bilayer and into the solution. 
As discussed earlier, the self-quenching of CF provides a convenient way to monitor its 
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efflux.  If the dye is released into the external solution by disrupting the vesicles, there is 
a large increase in the CF emission intensity.  This is illustrated by Figure 3.2, which 
shows several time traces obtained over the course of four weeks from V+ vesicles 
containing encapsulated CF.  For these experiments, a substantial volume of the CF/V+ 
sample was prepared on the first day and run through the SEC column to remove free dye; 
therefore, each trace in Figure 3.2 is for data acquired from the same preparation at a 
given number of days after SEC was run.  The traces show the emission intensity before 
and after the addition of Triton X-100, a nonionic detergent that disrupts both lipid and 
surfactant vesicles.19  As can be seen, the resulting release of dye into the solution causes 
a large jump in emission intensity, and the size of this jump is proportional to the amount 




Figure 3.2. Denaturation of catanionic vesicles and release of carboxyfluorescein.  Each 
time trace depicts detergent-induced denaturation of a 1.5 mL aliquot of 
carboxyfluorescein-loaded, CTAT-rich, catanionic vesicles taken from a single batch.  
The spike in fluorescence is due to the increase in carboxyfluorescein fluorescence 
efficiency as it is released upon disruption of the catanionic vesicles.  The scale bar 
shows the time scale for the individual traces and the day denotes the age of the sample. 
We note that the intensity jump reports on the encapsulated dye and not on the 
adsorbed dye, since addition of Triton X-100 to vesicle samples in which the dye was 
added after vesicle preparation did not produce an intensity jump.  As expected, the 
largest jump occurs for the freshly prepared vesicle solution where all the dye is 
encapsulated in the vesicles.  As described in the Chapter 2, we compare the magnitude 
of the jump on Day x with the highest jump (Day 0) and thereby obtain the fraction of the 
dye released on day x, R(t=x).   It should be noted that R(t) may actually underestimate 
the degree of dye retention since it does not account for dequenching occurring within the 
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vesicles as the dye leaks out.  This effect will be negligible in the catanionic samples 
since the dye concentration remains nearly unchanged over the time course of Figure 33.3. 
 
Figure 3.3. Comparison of dye released as a function of time, R(t), between equilibrium 
vesicles (solid line) and phospholipid vesicles (dotted line).  Release of 
carboxyfluorescein (CF) is shown as a function of time over a period of 27 days.  The 
half-life for release in catanionic vesicles is 84 days compared to 2 days in phospholipid 
vesicles, illustrating the enhanced stability of V+ samples. 
Plots of R(t) are shown in Figure 3.3 for CF in V+ (solid line) and EYPC (dotted 
line) vesicles.  First, consider the results for vesicles formed from EYPC.  Here, the dye 
is released rapidly over a period of about 5 days, yielding an estimated half-life of ca. 2 
days for the entrapped dye.  When R(t) reaches 1 there is no longer an increase in 
fluorescence emission upon addition of detergent, i.e., the dye concentration inside the 
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vesicles has equilibrated with that of the bulk solution.  Note that the equilibration takes 
place by transport across the membrane not by vesicle degradation, since the vesicles 
themselves are stable for up to several weeks.  In contrast to EYPC vesicle samples, V+ 
samples are able to encapsulate CF over a much longer period of time.  The release of CF 
is approximately 20% after 27 days giving an estimated half-life of 84 days for the 
entrapped dye.  DLS data taken over the 27-day course of the experiments show that the 
catanionic vesicle average radii remain unchanged and indicate that vesicle fusion or 
rupture is not occurring to any significant degree.  This indicates a fundamental 
difference in the permeability of V+ membranes to anionic solutes and in the overall 
vesicle stability compared with lipid vesicles.  We acknowledge that it is possible to 
obtain slower efflux rates in EYPC vesicles.  For instance, the addition of cholesterol or 
changes in lipid composition will improve the long-term encapsulation by EYPC 
vesicles.1-3   Xiang and Anderson1 show that the addition of  0.25 volume fraction of 
cholesterol to EYPC decreases membrane permeability by nearly 10-fold.  Here we show 
that catanionic vesicles achieve much better encapsulation stability without additional 
components. 
 
We have illustrated the ability for V+ to achieve dramatically different 
encapsulation of CF relative to those of EYPC vesicles.  At this point we do not know 
how general this observation is or whether these improved characteristics will emerge for 
other dyes or vesicle compositions.  The original motivation for investigating CF 
encapsulation was to provide a direct comparison with the well characterized CF/EYPC 
system.  Recently, Fischer et al. have reported that CTAT-rich vesicles are less 
 49 
 
permeable to glucose than SDBS-rich vesicles or vesicles prepared from the pure ion-pair 
amphiphiles.10  Future work is under way to determine whether the extraordinary ability 
of V+ to sequester CF is more than a mere curiosity and actually the first evidence of a 
general trend leading to important applications. 
 
3.4.  Conclusions and Discussions 
 
 
In summary, spectroscopic evidence has been presented supporting the capacity 
and long-term encapsulation of positively charged catanionic vesicles for anionic CF.  
The remarkable apparent encapsulation efficiency of 21% is assigned to electrostatic 
interaction between the anionic solute and the excess positive charge of the V+ bilayer.  
The long-term stability of the encapsulation is due to low membrane permeability.  
Previous studies have shown that fusion of catanionic vesicles occurs on a relatively long 
time scale of months.6  Here we have shown that the encapsulation of anionic solutes 
does not appear to radically alter this process.  Catanionic vesicles are promising 
candidates for high efficiency capture and long-term encapsulation of ionic solutes. 
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4.1.  Introduction  
 
 
   Vesicles have long been of interest to the scientific community for their ability to 
encapsulate solute molecules such as drugs or proteins. Most studies on solute 
encapsulation have been carried out with vesicles made from two-tailed amphiphiles 
(lipids).  However, single-tailed amphiphiles can also form vesicles1 and in particular, 
simple mixtures of cationic and anionic surfactants, often referred to as “catanionic” 
systems, can spontaneously give rise to unilamellar vesicles in water.3  A variety of 
catanionic vesicle-forming systems have been studied with respect to their phase 
behavior,4-11 but much less is known about the ability of these vesicles to capture, 
encapsulate and retain organic molecules.  
 
Recently, we published an initial report detailing some of the unique aspects of 
solute association with catanionic surfactant vesicles.12  Specifically, we showed that 
catanionic vesicles with a molar excess of the cationic surfactant (CTAT) efficiently 
captured the anionic dye 5(6)-carboxyfluorescein (CF), and retained it for very long 
periods of time (half life t1/2 of 84 days).
13  In the present study, we expand on our initial 
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investigation to include the anionic and cationic organic solutes shown in Figure 4.1.  In 
addition, we also study vesicle interactions with the cationic anti-cancer drug, 
doxorubicin.  Our results show that surfactant vesicles can be highly efficient for the 
capture and long-term storage of organic solutes that have a charge opposite to that of 
the vesicles.  Thus, there are strong, specific, charge-mediated interactions between 
vesicles and solutes, and we demonstrate how these interactions can be harnessed for 
efficient separation of oppositely-charged solutes from a solute mixture using only 
conventional, gravity-driven, size exclusion chromatography (SEC). 
 
The catanionic vesicles we focus on for this study are formed by combining the 
cationic surfactant, cetyltrimethylammonium tosylate (CTAT) and the anionic surfactant, 
sodium dodecylbenzenesulfonate (SDBS).8,14  The CTAT/SDBS system has been the 
most studied catanionic system, and the vesicles are known to be unilamellar and fairly 
monodisperse, with radii of 60-80 nm.8,13  Catanionic surfactant vesicles have been 
recognized to have several advantages over conventional phospholipid vesicles: they 
form spontaneously without the need for additional sonication or extrusion, they have an 
extremely long shelf life, and the raw materials are inexpensive compared to synthetic or 
purified phospholipids.  More importantly, this paper will demonstrate that catanionic 
vesicles have other advantages that have been hitherto unrecognized: they can efficiently 
capture and hold solutes that are of the opposite charge from the vesicles, and they retain 





4.2.  Experiment and Methods 
 
 
4.2.1.  Materials 
 
The surfactants CTAT, SDBS, and Triton X-100 were purchased from Aldrich 
Chemicals.  The fluorescent dyes CF, sulforhodamine 101 (SR101), and Lucifer yellow 
(LY) were purchased from Molecular Probes, while the dye rhodamine 6G (R6G) and the 
chemotherapeutic drug, doxorubicin hydrochloride (Dox) were purchased from Fluka. 
All materials were used without further purification.  The dry surfactants, CTAT and 
SDBS, were stored in a desiccator to prevent water absorption.  
 
4.2.2 Vesicle Preparation 
 
All samples were prepared at a total surfactant concentration of 1 wt.%.  The 
surfactants were weighed and mixed with deionized water by gentle stirring, and then 
allowed to equilibrate at room temperature for at least 48 h.8  Vesicle samples were 
prepared at two different surfactant compositions, 7:3 and 3:7 w/w CTAT to SDBS, 
which are denoted as V+ and V–, respectively.  V+ refers to the excess positive charge on 
the vesicle bilayers when there is an excess of CTAT.  In these samples, the 
concentrations of CTAT and SDBS are 15.4 mM and 8.6 mM, respectively.  This 
corresponds to 6.8 mM excess CTAT, or a 1.8 fold molar excess of cations.  Likewise, V– 
refers to vesicles with a net negative charge due to a 13.5 mM excess of SDBS (the 





4.2.3.  Methods 
 
4.2.3.1.  Evaluation of Apparent Encapsulation Efficiency (ε) 
 
The apparent encapsulation efficiency, ε, describes the fraction of dye in a 
particular preparation that associates with the vesicle either through entrapment in the 
inner water pool or by association with the vesicle bilayer.  The apparent encapsulation 
efficiencies of the two vesicle preparations, V+ and V–, were evaluated for all five solute 
molecules.  In each case, vesicles were prepared using aqueous solutions of the solute at a 
concentration of 1 mM.  In the case of CF, a pH ~9 was required in order to fully dissolve 
the dye, and the stock solutions were adjusted accordingly.  The solute/CTAT/SDBS 
mixtures were stirred for 30-60 min, and the resulting vesicle solutions were allowed to 
equilibrate in the dark at room temperature for at least 48 h.  Thereafter, the samples were 
passed through a 25 mm syringe filter (0.45 µm mesh) to remove any impurities or large 
aggregates.  Dynamic light scattering (described below) was conducted to confirm vesicle 
formation and to measure the average vesicle size. 
 
To measure the apparent encapsulation efficiency ε, SEC was used to separate the 
free solute from that which is captured by the vesicles.  A 1.0 mL aliquot of the vesicle-
solute sample was run through a 1.3 cm x 21 cm SEC column packed with Sephadex G50 
resin (medium mesh, from Amersham Biosciences).  During elution, 1.5 mL fractions 
were collected and analyzed, and a series of such fractions for a typical experiment is 
shown in Figure 4.2 (the solute here is CF).  Dynamic light scattering was used to 
determine which of the eluted fractions contained vesicles, and the vesicles were 
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consistently found to elute at 5.5 mL total elution volume.  The amount of solute in each 
fraction was determined using UV-vis spectroscopy (Hitachi U-3010 Spectrometer).  The 
ε value is defined as the amount of vesicle-associated solute relative to the total initial 





AAV ...)( 21 ++
=ε  (1) 
where V and A are volume and absorbance and i denotes initial values taken from the 
original preparation and f denotes values taken from the fractions eluted from the SEC 
column shown by dynamic light scattering to contain vesicles.  To avoid artifacts in UV-
vis spectroscopy from light scattering or from solute aggregation inside the vesicles, the 
absorbance was determined after first disrupting the vesicles by adding Triton X-100 
surfactant to each fraction.  Note that ε reflects contributions from both the solute in the 
water pool inside the vesicle and the solute that is electrostatically adsorbed on the 
vesicle bilayers. 
 
4.2.3.2.  Long-Term Capture and Dye Release 
 
To evaluate the ability of vesicles to retain solutes for long periods of time, the 
following procedure was adopted.  First, the initial vesicle-solute mixture was purified 
using SEC (as described above) to remove the free solute.  The sample was then checked 
for release of solute from the vesicles over the course of several weeks.  For this purpose, 
quick-spin columns pre-packed with Sephadex G50 (fine) were used (column from 
Roche, additional beads for repacking the columns from Sigma).  On a specific day, a 
100 µL aliquot was run through a quick-spin column by centrifugation (3000 rpm, 15 s), 
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and the eluted fraction was evaluated using UV-vis spectroscopy.  Any solute that had 
been released from the vesicles was retained by the quick-spin column.  Therefore, the 
amount of solute eluted by the column corresponded to the solute still associated with the 
vesicles.  The UV-vis absorption value for the eluted sample was divided by the 
corresponding value obtained on day zero (immediately after SEC) to yield a fraction of 
solute that remains captured by the vesicles.  The above procedure was repeated at 
various times to create a release curve (i.e., released solute vs. time elapsed, as shown in 
Figure 4.3).   
 
4.2.3.3.  Dynamic Light Scattering (DLS)  
 
 Vesicle sizes in solution were monitored using DLS on a Photocor-FC instrument. 
The light source was a 5 mW laser at 633 nm and the scattering angle was 90°.  A 
logarithmic correlator was used to obtain the autocorrelation function, which was 
analyzed by the method of cumulants to yield a diffusion coefficient.  The apparent 
hydrodynamic size of the vesicles was obtained from the diffusion coefficient through the 
Stokes-Einstein relationship.  The intensity (total counts) of the signal was also recorded 
for each sample.   
 
4.2.3.4.  Small Angle Neutron Scattering (SANS) 
 
SANS experiments were conducted on the neat vesicles as well as the vesicle-
solute mixtures to probe whether there were any changes in vesicle size or bilayer 
 57 
 
integrity caused by the solutes.  All samples for SANS experiments were prepared using 
deuterium oxide (99%D, from Cambridge Isotopes) in place of water. The measurements 
were made on the NG-7 (30 m) beamline at NIST in Gaithersburg, MD.  Neutrons with a 
wavelength of 6 Å were selected.  Two sample-detector distances of 1.33 m and 13.2 m 
were used to probe a wide range of wave vectors from 0.004 – 0.4 Å-1.  Samples were 
studied in 2 mm quartz cells at 25°C.  The scattering spectra were corrected and placed 
on an absolute scale using calibration standards provided by NIST.  The data are shown 
as the radially averaged intensity I (minus the background) versus the wave vector q = 
(4π/λ) sin(θ/2), where λ is the wavelength of incident neutrons and θ is the scattering 
angle.  Analysis was carried out as described previously.15   
 
4.3.  Results and Discussions  
 
We have shown in our initial report13 that the anionic dye, CF, can be efficiently 
sequestered in CTAT-rich vesicles (V+) via two mechanisms: encapsulation in the inner 
water pool and electrostatic adsorption to the charged bilayer.  The apparent 
encapsulation efficiency ε, measured by the procedure described above in the 
Experimental Section, was found to be about 22%.  Electrostatic adsorption contributed 
about 75% of the ε value, as shown by experiments where the CF was added to pre-
formed V+ vesicles.  Conversely, the ε for CF in SDBS-rich vesicles (V–) was only ca. 
1%, which was comparable to the ε for CF encapsulation in neutral phospholipid (egg 
yolk-phosphatidyl choline, EYPC) vesicles.  These observations confirmed that the 
unusually high apparent encapsulation efficiency in V+ vesicles was likely due to 
electrostatic interactions of the dye with the vesicles. Studies in which dye adsorption 
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decreases with increasing ionic strength (data not shown) also confirm that electrostatics 
play a principle role.  In addition to apparent encapsulation efficiency, we also studied the 
time-dependent release of CF from the vesicles by utilizing the self-quenching of CF 
fluorescence.  We found that the release rate from V+ surfactant vesicles was at least 40 
times slower than from EYPC vesicles.      
 
In this chapter, we have expanded our studies to include two new anionic dyes, 
LY and SR101, as well as two cationic solutes, the dye, R6G and the anti-cancer drug, 
Dox.  We have measured the initial value of ε for each of these solutes in both V+ and V– 
vesicles and monitored ε as a function of time for three different solute/vesicle 
combinations.  To demonstrate the strength and specificity of vesicle capture, we have 
also used the vesicles to separate an oppositely charged solute from a solute mixture. 
These studies indicate that surfactant vesicles are promising candidates for applications 
such as drug delivery and molecules separation.  An important requirement for realizing 
such applications will be to ensure the stability of vesicle-solute mixtures under a range 
of conditions.  To investigate the issue of vesicle stability upon addition of solutes, we 
have conducted an initial set of studies using DLS and SANS, and these are reported in 
the last section of this chapter.  
 
4.3.1.  Capture of Charged Solutes by Vesicles 
 
The chemical structures of the five different solutes studied here are shown in 
Figure 4.1.  CF is a trianionic fluorescent dye at a pH above 6.916, while LY is dianionic 
in water and SR101 is monanionic.  R6G possesses a quaternary amine, is cationic at all 
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pH, and was chosen for its structural similarities with CF.  Dox is a cationic drug with a 
pKa of ~ 7.617  that has been used to treat a variety of cancers.18-20  In fact, the toxic side 




Figure 4.1.  Structures of the five solutes used in these studies. 
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The apparent encapsulation efficiency, ε, for each of the above solutes was 
determined for both V+ and V– vesicles using the procedure described in the 
Experimental Section.  It is important to point out that a solute concentration of 1 mM 
was used in all cases. In an earlier study, Caillet et al. attempted to encapsulate CF in V+ 
catanionic vesicles, but their attempt failed due to the high CF concentration (50 mM) 
used.21  It has been well documented that addition of polyelectrolytes to oppositely 
charged surfactant vesicles can destabilize vesicles leading to changes in bilayer and 
vesicle structure as well as precipitation.22,23  Consistent with these findings, we have 
found that high concentrations of CF (and similarly, other solutes) tend to disrupt the 
vesicles and lead to precipitation over time.  Vesicle stability appears to be unaffected 
when the solute concentration is kept below 5 mM, and at these concentrations solute 
capture does occur.  The results of experiments using 1 mM CF in V+ and V– vesicles are 
shown in Figure 4.2.  The photographs show successive eluted fractions (1.5 mL each) 
from the SEC column for V+ vesicles (Figure 4.2a) and V– vesicles (Figure 4.2b).  The 
vesicle-containing fractions are in vials 3-5 (fractions 4-6) in both cases, and this is 
evident from the high DLS intensity for these samples (plotted as a solid line in the 
graphs).  In addition, the fraction of CF in each vial (from UV-vis) is also plotted as a 
yellow dotted line.  Note that vials 3-5 in the case of V+ have a strong yellowish tinge, 
confirming that these vesicles contain an appreciable fraction of CF (23%).  On the other 
hand, vials 3-5 in the case of V– vesicles have a much lower dye content (1.5%).  Thus, 






Figure 4.2. Results from SEC of vesicles with the anionic dye, CF: (a) V+ vesicles; and 
(b) V- vesicles. The plots on the right show the DLS intensity, which is proportional to 
vesicle concentration, and the UV absorbance at 492 nm, which is proportional to CF 
concentration, as a function of eluted volume. The results show that a significant portion 
of the dye (23%) elutes with the V+ vesicles, whereas only about 1.5% of the dye elutes 
with the V- vesicles. This can be seen visually by the more intense yellowish hue of the 
vesicle fractions (vials 3-5) in the V+ case. 
 
Similar results (highly efficient capture in V+, weak encapsulation in V–) were 
obtained for the other two anionic dyes (LY and SR101) as well.  For the cationic solutes 
(R6G and Dox), the results were switched and these solutes are efficiently captured in V– 
samples and weakly in V+ samples.  Counterparts to Figure 4.2 with photographs, DLS 
intensity, and UV-vis absorbance data, for each of the solutes are provided in Appendix 
A.  Table 4.1 shows the ε values (calculated using eq. 1) for each solute in both V+ and 
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V– vesicles.  It is clear from these data that ionic solutes are efficiently captured in 
catanionic vesicles having an opposite net charge.  
 
 
 ε (Apparent 
Encapsulation Efficiency) 
Vesicle Radius after SEC by DLS 
(nm) 








CF 24 ± 4 % 1.0 ± 0.4 % 87 ± 5  91 ± 8  
LY 40 ± 20 % 4 % 208 ± 18  96 ± 3  
SR101 32.8 % 8.2 % 122 ± 38  84 ± 7  
R6G 0.07 ± 0.1 % 72 ± 3 % 156 ± 24  109 ± 16  
Dox 0% 55 % 143 ± 32  93 ± 4  
 
Table 4.1. Apparent encapsulation efficiencies and vesicle radii.  The ε values were 
determined as described in the Experimental Section. ε includes contributions from probe 
molecules that are both encapsulated in the inner water pool and adsorbed at the vesicle 
bilayer.  Vesicle radii are reported for the vesicle-containing SEC fractions only.  Vesicle 
radii were determined by DLS and the radii for neat vesicles (no probe molecules) 
obtained after SEC are given in parentheses in the column headings.  Radii for V+ and V- 
samples before SEC are 74 nm and 70 nm, respectively. 
 
 
One interesting observation from Table 4.1 is that the ε values for cationic solutes 
in V– vesicles are remarkably high: ε is 72% for R6G and 55% for Dox.  These values are 
much higher than those for the anionic solutes in V+ vesicles and may stem from the 
larger excess charge present in V-, i.e. 13.5 mM vs. 6.8 mM.  In addition, this difference 
may also result from the relative lipophilicities of the counterions for the two surfactants, 
these being tosylate in the case of CTAT and sodium in the case of SDBS.  Tosylate (p-
toluene sulfonate) is a hydrophobic counterion, and will mostly (> 90%) remain bound to 
the trimethylammonium headgroup in CTAT, with the aromatic ring of tosylate 
intercalating into the vesicle bilayer.8,14  The bound tosylate counterions will reduce the 
cationic charge of the bilayer and, in turn, the strength of interactions between anionic 
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solutes and the bilayer will be reduced. In comparison, the sodium counterions in SDBS 
will be largely dissociated, and therefore the sulfonate headgroups will present a strongly 
negative bilayer surface for electrostatic binding of cationic moieties.  
 
Next, we turn briefly to the issue of solute adsorption. In our previous chapter, we 
reported that electrostatic adsorption of CF to the V+ vesicle bilayer made a significant 
contribution to the apparent encapsulation value, ε.  The contribution from electrostatics 
was obtained by adding the CF to pre-formed V+ vesicles, and then measuring the 
apparent encapsulation.  This resulted in an ε value that was 75% of that measured by the 
conventional method. In the present study, we have conducted similar experiments with 
the cationic R6G dye and found that if the dye is added to pre-made V– vesicles, we 
obtain an ε that is ca. 85% of the value reported in Table 4.1.  Thus, the electrostatic 
contribution to solute binding is crucial for both V+ and V- vesicles.  Dye adsorption at 
the vesicle bilayer is being investigated systematically, and will be the subject of a 
separate chapter.24 
 
4.3.2. Long-Term Solute Release from Vesicles   
 
In our previous paper, we used the self-quenching properties of CF fluorescence 
to evaluate the release rate of CF from V+ vesicles.13  This is a well-established method to 
study solute release from vesicles,25,26 but it can only be applied to fluorescent solutes 
that show the self-quenching phenomenon.  Here, we measure release rates using a more 
general procedure based on SEC that can be applied to a wide range of solutes, including 
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non-fluorescent ones.  The details of the procedure are described in the experimental 
section.  Briefly, we start with a batch of solute-bearing vesicles, with the free dye 
removed using SEC.  The amount of solute remaining in the vesicles is evaluated at a 
later time by removing an aliquot and performing a small-scale separation using a quick-
spin column.  Our method directly yields the apparent encapsulation, ε, as a function of 
time.  
 
Figure 4.3. Dye release profiles.  Long-term release as a function of time.  Data was 
acquired for CF (red squares) and LY (empty red circles) in V+ samples, and R6G (black 
circles) in V- samples.  The corresponding lines are fits to an exponential decay. For CF 
in V+, three trials were completed and the error bars on the points are the standard 
deviations of the averages of the three data sets.  For R6G and LY, two trials were run 




Figure 4.3 shows ε vs. time data for three different solute/vesicle combinations. 
The data for CF in V+ vesicles (red squares) are quite comparable to our previous results 
for the same CF/V+ system using the self-quenching of CF.  The new data gives a half 
life for CF in the vesicles of 114 days, while previously we had estimated an 84 day half-
life for the same system from a more limited data set.  Also shown in Figure 4.3 are 
results for LY in V+ vesicles (empty red circles) and R6G in V– vesicles (black circles). 
The ε values for both LY and R6G start out significantly higher than that of CF in V+, but 
decay over the course of a few days to a comparable value of ε (from 0.2 to 0.3).  R6G 
has the largest initial rate of dye leakage, which could be because it is captured to a much 
greater extent than the other two dyes (Table 4.1).  On the whole, our new results confirm 
that oppositely charged solutes can be held for very long periods of time by catanionic 
vesicles.  For comparison, the half-life for CF in EYPC liposomes is only about 2 days,12 
which means that the surfactant vesicles retain ionic dye for about 40-60 times as long.    
 
4.3.3.  Separation of Oppositely Charged Solutes by Vesicles 
 
The strong electrostatic interactions between catanionic vesicles and ionic solutes 
may be harnessed for an interesting potential application: separation of an oppositely 
charged solute from a solute mixture.  To test this possibility, we prepared vesicles with 
equimolar mixtures of two solutes, one cationic (R6G) and the other anionic (CF).  The 
total solute concentration was maintained at either 0.5 or 1.0 mM, and the experiments 
were done with both V+ and V– vesicles.  Experiments with these solute mixtures were 
performed and analyzed in exactly the same way as the determination of ε.  To account 
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for the overlapping of the dye spectra, we subtracted a scaled spectrum of pure R6G from 
the total spectrum in order to find the peak absorbance of CF.  
 
Figure 4.4. Vesicle-mediated separation of mixtures of R6G and CF dyes using (a) V+ 
vesicles; and (b) V- vesicles. The plots on the right show the DLS intensity, which is 
proportional to vesicle concentration, and the UV absorbances, which are proportional to 
the concentrations of R6G and CF, as a function of eluted volume. The results show that 
the V+ vesicle fractions contain 31% of the CF with no detectable R6G, while the V- 
vesicle fractions contain 88% of the R6G with no detectable CF. This can be seen 
visually by the yellowish hue of the V+ vesicle fractions compared to the pinkish hue of 
the V- vesicle fractions. 
 
Results from an equimolar mixture of CF and R6G, at a total dye concentration of 
0.5 mM, in V+ vesicles are shown in Figure 4.4a.  While 31% of the anionic CF is carried 
through the SEC column within the V+ vesicle band, no detectable R6G emerges with the 
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vesicles.  In short, the V+ vesicles are able to selectively capture the anionic dye, and 
thereby separate it from the dye mixture.  The opposite behavior is observed for the same 
dye mixture in V– vesicles (Figure 4.4b).  In this case, the V– vesicle band emerging from 
the SEC column contains 88% of the R6G, while the amount of CF in this band is 
negligible.  Thus, the V– vesicles are able to bind and separate the cationic dye from the 
dye mixture.  To our knowledge, this is the first demonstration of the use of  surfactant 
vesicles to separate ionic compounds.  We conducted the same experiments with a total 
dye concentration of 1.0 mM CF and R6G, and obtained similar results.  We have also 
conducted separation experiments using the anionic dye, LY and the cationic drug, Dox, 
and we again observed very efficient separation using vesicles, much like in Figure 4.4. 
The results for LY and Dox are given in the Appendix A.  These results demonstrate that 
charged surfactant vesicles can be used as separation media for similarly-sized and 
oppositely-charged molecules.  The use of surfactants in separations science is not new, 
micelle containing mobile phases in liquid chromatography were pioneered by Armstrong 
and Henry.28  Since then, micellar liquid chromatography has been widely used for a 
variety of applications including evaluation of drug candidates.29,30  Surfactant vesicles 
themselves have also been used as pseudostationary phases for electrokinetic 
chromatography with good results.31 
 
4.3.4.  Effects of Solutes on Vesicle Stability 
 
It is clear from the above data that catanionic vesicles have the remarkable 
capability of binding and slowly releasing oppositely charged solutes.  But for these 
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vesicles to be used in applications, certain questions relating to vesicle stability need to 
be answered.  For example, what effect, if any, does the solute have on vesicle size and 
stability? Why is it important to use low solute concentrations (< 5 mM), i.e., what 
happens to the vesicles when higher concentrations of solute are added?  Also, for many 
biological applications, the pH and ionic strength of the external solution have to be 
strictly controlled.  How will pH and ionic strength affect vesicle stability, and more 
importantly, how will they influence the electrostatic binding of solutes to vesicles? 
Many of these aspects are being studied in detail in our labs, and will be addressed in the 
future.  In the present study, we briefly examine the effect on vesicle stability upon 
addition of solute, using SANS and DLS.    
 
As noted previously, we used a low solute concentration (1 mM) to ensure the 
stability of our vesicle formulations.  At concentrations above 5 mM, the solutes seemed 
to compromise the integrity of the vesicles, as revealed by large changes in vesicle size 
(from DLS) and/or by the formation of a precipitate over time.  Even at a concentration 
of 1 mM, some solutes may have a large effect on vesicle morphology.  To study these 
aspects in some detail, we have used DLS and SANS.  First, we performed DLS on the 
purified vesicles obtained from the SEC column (after removing all the free solute) and 
compared their sizes to those for the neat vesicles (no solute).  DLS gave radii of 74 nm 
for neat V+ vesicles and 70 nm for neat V– vesicles.  Passing these neat vesicles through 
an SEC column changed their sizes slightly and the new radii were 81 nm for V+ and 
98 nm for V– vesicles due to the dilution.  The incorporation of 1 mM solute had a 
negligible effect on vesicle size in some cases, but a large effect in others (Table 4.1). For 
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example, both V+ and V– vesicle radii were essentially unchanged by 1 mM CF.  
However, while 1 mM of the anionic solute, LY had no effect on V– vesicles, it induced a 
2.5 fold increase in the radii of V+ vesicles. Interestingly, the effects on vesicle size seem 
to be more significant for V+ vesicles than for V–, and this is true for both cationic and 
anionic solutes.  The changes in hydrodynamic radii are an important indicator that 
structural changes are occurring in the presence of ionic solutes.  Results from our lab 
indicate that these vesicles are stable at elevated salt concentrations.  Thus, it is unlikely 
that the size increases are due to simple flocculation brought about by increasing ionic 
strength upon addition of solute.  Direct imaging techniques such as cryogenic 
transmission electron microscopy (cryo-TEM) may be able to reveal the solute induced 
changes indicated by DLS.  However, at this time, we do not have access to cryo-TEM 




Figure 4.5. SANS data for neat and dye-containing V+ and V- samples.  (a) Scattering 
data for V+ samples.   A -2 slope characteristic of bilayer scattering is observed for neat 
vesicles (black circles) and when CF is added before (red triangles) or after (blue squares) 
vesicles are formed.  (b)  Scattering data for neat V- samples (black circles) and for V- 
loaded with R6G (red triangles). As in (a), the data from both samples are consistent with 
the presence of vesicles.  The neat vesicle samples (black circles) were run as-prepared 
with 1% total surfactant concentration.  The other samples (blue squares and red triangles) 
were diluted by approximately 4-fold as a result of undergoing SEC. 
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SANS data are reported in Figure 4.5 for two mixtures of vesicles and oppositely 
charged solutes: V+/CF, and V–/R6G. Figure 4.5a shows data for the neat V+ vesicles 
with no solute, and for the same vesicles prepared with 1 mM CF and purified by SEC. 
Additionally, data are shown for a sample of the same vesicles with 1 mM CF added after 
preparation (i.e., with the dye adsorbed on the bilayers), followed by purification via SEC.  
Passing the vesicles through SEC lowers the vesicle concentration, which is why the 
latter two data sets show a lower intensity.  Nevertheless, all three curves have 
approximately the same shape and all show a limiting slope of –2 at low q, which is 
indicative of scattering from vesicle bilayers.32,33  Similar observations also hold for 
Figure 4.5b, which reports data for neat V– vesicles and for the same vesicles with 1 mM 
R6G followed by SEC.  Again, the intensity levels are lower due to the SEC purification, 
but the –2 slope is maintained.  Thus, SANS confirms that all these samples contain 
intact unilamellar vesicles.  In all cases, there appear to be subtle differences in vesicle 
size and polydispersity upon incorporation of solute.  Further analysis of the SANS data 
is beyond the scope of the present paper.  However, we are putting together an expanded 
study of solute/vesicle interactions using SANS, accompanied by detailed modeling, and 
this will be communicated in the future.  The combined observations from DLS, SANS 
and SEC experiments strongly indicate that the vesicles remain intact in the presence of 
dyes though precipitation has been observed when dye concentrations exceed 5 mM. 
 
4.3.5.  Implications for Applications Involving Surfactant Vesicles  
 
As discussed in the introduction of this section, important potential applications 
for vesicles are in storage or controlled release applications (e.g., in drug delivery, 
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agrochemicals, or cosmetics).  This is an area of great promise, as evidenced by the 
success of the liposome-based delivery of the chemotherapeutic drug, doxorubicin.34  So 
far, most of the research in this area has focused on phospholipid vesicles (liposomes). 
Researchers working with liposomal encapsulation technologies have discovered many 
improvements in solute loading efficiency and long-term solute retention.  For instance, 
there has been progress in enhancing the long-term retention capabilities of liposomes by 
varying the lipid composition of the bilayer or by adding cholesterol to the bilayer. 
Similarly, there have been successful attempts to reach extremely high loading efficiency 
of drugs like doxorubicin by employing chemical gradients.37  Loading of DNA into 
vesicles can be greatly improved with the addition of cationic lipids38 or by using micron-
sized vesicles.39  Such advances in liposomal preparations have led to important advances 
in chemotherapy.  Here, we have shown that catanionic vesicles may show promise as a 
simple alternative to more expensive and complex liposomal-based approaches.  In short, 
catanionic vesicles could be an attractive alternative to phospholipid vesicles (liposomes) 
for many controlled-release applications.  For therapeutic applications, a range of 
toxicological studies will first need to be conducted with these catanionic vesicles.  In 
this regard, recent studies by Kuo et al. are promising in that they show catanionic 
vesicles to be nontoxic towards mouse fibroblast and liver cells.40   
 
4.4.  Conclusions       
 
         
 In this study, we have measured the apparent encapsulation of five different 
charged solutes in catanionic CTAT/SDBS vesicles and used these vesicles to separate an 
oppositely charged solute from a solute mixture.  We have shown that solutes can be 
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weakly encapsulated by like-charged vesicles but are captured much more efficiently in 
oppositely charged vesicles.  Efficient containment in vesicles of the opposite charge is 
due to strong electrostatic interactions between solute and bilayer.  At 1 mM solute 
concentrations, apparent encapsulation values range from 24% to 72%.  Long-term solute 
release kinetics were monitored for three vesicle/solute preparations.  Release profiles 
show that all dyes are held for long periods of time but that both R6G, and to a lesser 
extent LY, have an initial rapid dye release that bring them close to the initial value for 
CF.  Highly efficient separations of mixtures of similar sized but oppositely charged 
probe molecules were performed by using vesicles to control the elution time of ionic 
probe molecules in SEC.  Results from DLS and SANS experiments are also included to 
measure the effect of solute loading on vesicle integrity and stability.  DLS results show 
that V+ samples appear to undergo an increase in radius when solutes are added at a 
concentration of 1 mM but that the effect on SDBS vesicles is negligible.  SANS 
experiments confirm that vesicles remain intact when loaded with strongly-interacting 
probes.  
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5.1.  Introduction 
 
First reported by Kaler et al. in 1989, surfactant vesicles are an intriguing 
alternative to liposomes.1  These large unilamellar vesicles form spontaneously from 
mixtures of oppositely-charged single-tailed surfactants, and are extremely stable.1,2  
Surfactant vesicles are relatively unique in their ability to form spontaneously from 
simple two-component mixtures of surfactants.  Vesicles are often observed to form 
spontaneously in vivo, but prior to Kaler et al. very few instances of vesicles formed 
spontaneously in vitro were known, and the few reported in the literature were formed 
from mixtures of surfactants.3-6  According to Kaler et al., the fact that the vesicles 
formed without the input of mechanical energy and were stable and free of aggregation 
for long periods of time meant that they could be classified as equilibrium structures.  
Whether the surfactant vesicles formed truly constitute an equilibrium state has been the 
subject of some debate,7,8 but the fact remains that these unilamellar vesicles form easily 
in aqueous environments and are stable for long periods of time.  An additional attraction 
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of surfactant vesicles is that they can be formed from relatively cheap, commercially 
available surfactants. 
 
We have been investigating surfactant vesicles formed from sodium 
dodecylbenzenesulfonate (SDBS) and cetyltrimethylammonium tosylate (CTAT) for use 
as molecular vehicles in applications such as disease diagnostics or drug delivery.9-11  The 
surfactant portion of CTAT (CTA+) is positively charged due to a trimethylammonium 
headgroup and each molecule is coupled with a tosylate counter ion, as seen in (Figure 
5.1.).  The surfactant portion of SDBS (DBS-) is negatively charged due to a sulfonate 
headgroup, and the salt contains sodium as the counterion.  In solution, the two charged 
surfactants form an ion pair that resembles a phospholipid molecule with a zwitterionic 
headgroup and two hydrophobic tails, and achieve the geometry necessary for the 




Figure 5.1.  Structure of surfactants and illustration of bilayer formation. 
Although the surfactants are thought to form 1:1 ion pairs, experiments have 
shown that it is necessary to have an excess of one of the surfactants in order for vesicle 
formation to occur.  Kaler theorized that the excess surfactant helped to fluidize the 
vesicle bilayer.1  The necessity of one surfactant being in excess can further be explained 
by examining the property of spontaneous curvature.  The monolayers making up a 
bilayer each have a spontaneous curvature arising from the packing of the amphiphiles.  
If the packing area of the polar heads is smaller than the packing area of the hydrophobic 
tails due to head-head interactions being more favorable than tail-tail interactions, then 
the monolayer tends to bend so that the non-polar region is on the outside of the curved 
monolayer.  If the head packing favors a larger area, then the opposite occurs and the 
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non-polar region is on the inside of the monolayer.12  For single-component bilayers the 
spontaneous curvatures of the two monolayers exactly cancel and the net spontaneous 
curvature is zero, meaning any deviation from a flat bilayer costs energy.2  Shortly after 
Kaler’s report on surfactant vesicles, Safran et al.13 presented a model to explain the 
unusual stability of vesicles formed from surfactant mixtures.  Through various 
calculations he determined that it is possible to obtain spontaneous curvatures for the two 
monolayers that are equal and opposite (allowing a curved bilayer) if the inner and outer 
monolayers have differing compositions.  This can be achieved through the presence of 
the excess, unpaired surfactant molecules.  If more of the unpaired surfactants (which 
have a large headgroup relative to tail size) are placed in the outer monolayer and more of 
the zwitterionic complexes (which have a small headgroup relative to tail size) are placed 
in the inner monolayer, it is possible to obtain the appropriate spontaneous curvatures and 
achieve curved bilayers and spontaneous vesicle formation. This is shown in Figure 5.1. 
Ion pairing of the oppositely charged surfactants and the presence of an excess of one 
surfactant are both necessary for the formation of highly stable vesicles.  Furthermore, 
each vesicle carries a net charge which is predominantly located at the external 
bilayer/water interface. 
 
DNA adsorption at the external bilayer interface of surfactant vesicles has been 
studied with an eye toward using these systems as non-viral transfection vehicles.14-16  
Letizia et al. obtained a binding isotherm and equilibrium constant for lysozyme 
adsorbed to surfactant vesicles formed from sodium dodecylsulfate (SDS) and 
cetyltrimethylammonium bromide (CTAB).17  Recently we showed that favorable 
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electrostatic interactions with the vesicle bilayer can lead to very efficient capture and 
sequestration of charged organic molecules.11  In our work, we have found that as much 
as 75% of the sequestered molecules are bound to the exterior surface of the vesicle.10  In 
this chapter we study the binding of dye molecules to the charged vesicle exterior and 
also examine the effects of surfactant stoichiometry and excess salt concentration on the 
adsorption isotherm.  To achieve this we make use of fluorescence correlation 
spectroscopy (FCS).18 
 
FCS measures the diffusion time of a fluorescing species as it passes through a 
laser beam and is a quick and sensitive measurement for monitoring the binding of a 
small particle such  as a molecule or low molecular weight polymer to a much larger 
particle such as a vesicle or bead.19,20   In our case, if the fluorescing molecule is bound to 
the vesicle it diffuses much more slowly than a free molecule and the fraction of bound 
molecules is easily determined by fitting the fluorescence fluctuation autocorrelation 
function.  For our purposes, FCS is an ideal tool since it is suited for very low probe 
concentration and provides a simple and accurate way to measure binding isotherms well 
below the binding saturation regime.  In addition, working at low probe concentration 
also ensures that vesicle stability is not compromised as can happen when higher 
concentrations, above 5 mM, are used.11  Figure 5.2. shows the structures of the dye 









5.2.  Materials and Methods 
 
5.2.1.  Materials 
 
 Surfactants CTAT, CTAB, were purchased from Aldrich. SDBS, was purchased 
from Tokyo Chemical Industry (in USA) and Triton X-100 was obtained from Fisher 
Scientific.  Fluorescent dyes 5-(and 6-)carboxyfluorescein (CF), 1,1’-dioctadevyl-
3,3,3’,3’-tetramethylindocarbocyanine perchlorate (DiIC18), and sulforhodamine 101 
(SR101) were from Invitrogen and chemotherapeutic drug doxorubicin hydrochloride 
(Dox) was obtained from Fluka.  Materials were used without further purification.  Dry 
surfactants CTAT, CTAB, and SDBS were stored in a desiccator.  Saline solution was 
purchased from CVS Pharmacy. 
 
5.2.2.  Measuring Encapsulation Efficiency 
   
Dye-vesicle mixtures were run through a long Pyrex (45mm x 13mm) size 
exclusion chromatography column with Sephadex G-50 Medium.  Fractions were 
collected and analyzed for vesicles with dynamic light scattering (DLS) and dye 
concentration with a UV-Vis spectrophotometer.  Triton X-100 was added at 1% v/v to 
all UV-Vis samples to disrupt vesicle structure and allow for accurate measurement of 
dye absorbance. Encapsulation efficiency was calculated from the sum of absorbance of 
1.5mL of each fraction containing vesicles divided by the stock solution (pre-SEC 
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5.2.3.  Fluorescence Correlation Spectroscopy 
  
FCS was performed with a previously described set-up21 consisting of an air-
cooled argon ion laser (532-AP-A01, Melles Griot, Carlsbad, CA), an inverted 
microscope (Axiovert 200, Carl Zeiss, Göttingen, Germany), and a single photon 
counting avalanche photodiode, or APD (SPCM-AQR-15, Perkin Elmer, Vaudreuil, QC, 
Canada).  The collimated laser beam (λ= 488 nm or 514 nm depending on the dye) was 
focused into the sample solution approximately 10 µm from the coverslip surface using a 
100X, 1.30 N.A. oil immersion objective (Fluar, Carl Zeiss).  A nearly diffraction limited 
spot with a lateral radius of r=360 nm was achieved.  Typical laser power was 5 µW.  
Fluorescence was collected through the objective and filtered ( Holographic notch filter, 
HNF-488.0-1.0, Kaiser Optical System, Inc. Ann Arbor, MI or RazorEdge filters, LP01-
514RS-25, Semrock, Rochester, NY ) to remove scattered excitation light.  Collection 
optics consisted of a pair of achromatic doublets placed after the primary image plane and 
were used to match the size of the colleted fluorescence spot with the 180 µm diameter 
area of the APD.  The output of the APD was fed to a counter timer board (PCI-6602, 
National Instruments, Austin, TX) operating in time-tagged photon counting mode using 
home written software in LabView (National Instruments, Austin, TX.). 
   
Time-tagging mode plots time between photon counts versus the count number 
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elapsed time from the start of a run to each photon count, saving previous time and 
memory and hard drive space (think dozens of gigabytes of hard drive space and weeks 
of time saved) in subsequent autocorrelation analysis of data.  The “time-tags” are used to 
reconstruct the photon intensity transient or autocorrelation curve.  Temporal resolution 
for timed tagged data is limited by the dead-time of the APD (50 ns) and the on-board 
clock of the counter/timer board (80 MHz).  The time tagged data were autocorrelated 
off-line using routines home written with Igor Pro 5.0 (Wavemetrics, Portland, OR) 
according to the following equation:21 
 











=                                        (2) 
Figure 5.3 shows fluorescence fluctuation autocorrelation decay curves acquired 
for CF at concentrations ranging from 1-10nM.  The decays are fit with the functional 





Figure 5.3. Autocorrelation decays for the samples containing the dye 
carboxyfluorescein in water at room temperature.  The solid lines show the fits to 
Equation 2 for each set of data.  Each fit gave a diffusion time of ~270 µs which 
corresponds to a diffusion coefficient of 1.2 x 10-6 cm2 s-1.  The amplitudes vary inversely 
with the concentrations and are given in the legend.  In all fits ω was held at 3.0. 
 











































τ                           (3) 
 
where C is inversely proportional to the average number of molecules in the observation 





=τ  where D is the diffusion 
coefficient) and ω2 is a factor proportional to the ratio of the radial and axial axes of the 
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three dimensional observation volume.22,23  The best-fit parameters for the three curves in 
Figure 5.3 are consistent with expectations, yielding amplitudes that are inversely 
proportional to concentration and diffusion coefficients that match previously measured 
values ( 126105.1 −−×≈ scm ).24   
  
The adsorption of dye molecules to surfactant vesicles was studied by adding 
preformed vesicles to dye solutions.  In all cases the dye concentration was 10 nM with 
varying surfactant concentrations.  These samples were studied with FCS and the 





















































































τ             (4) 
 
where f is the fraction of probe molecule (dye) that is bound to vesicles.  The diffusion 
times for vesicles and dye molecules are τv and τp, respectively.  Diffusion times for 
probe molecules are determined from the autocorrelation decay of free dye in the absence 
of vesicles.  The vesicle diffusion time is determined  from the autocorrelation decay of 
vesicles doped with a low concentration (1nM) of the dye DiIC18.  DiIC18 has a structure 
similar to an amphiphilic surfactant, causing it to act as a surfactant rather than an 
externally bound dye, integrating into the vesicle bilayer and offering a vehicle for 
making vesicles fluorescing species, a necessity for finding their diffusion time by FCS.  
When fitting autocorrelation functions from mixtures of dye and vesicles, the diffusion 
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times were held constant and only the value of f was varied, despite the fact that the 
quality of some fits are not so high as can be obtained if the diffusion times are also 
allowed to vary. Results from binding studies of CF on CTAT-rich vesicles along with 
their corresponding fits are shown in Figure 5.4.  The fraction of bound dye, f, was 
plotted against surfactant concentration to obtain a binding isotherm for the different 
systems.  In general, the fits were consistent for samples run on different days allowing 
us to construct isotherms with good reproducibility, shown in Figure 5.4.  For each 
surfactant concentration, ranging from 1pM to 1nM, 10 2-minute decays were collected.  
The autocorrelations of each data were compared to check for consistency and then 
averaged.  Each autocorrelation decay curve in Figure 5.4 is thus constructed from 




Figure 5.4. Normalized autocorrelation functions obtained from carboxyfluorescein     
(10 nM) with varying amounts of CTAT-rich vesicles. 
 
5.3.  Results and Discussion 
 
  We previously showed that surfactant vesicles formed from mixtures of the 
surfactants CTAT and SDBS are highly efficient at capturing small solute molecules of 
the opposite charge from the vesicle bilayer.10,11  FCS was performed with a number of 
different vesicle/dye combinations.  By varying the surfactant concentration we were able 
to construct binding isotherms for each combination.  The binding isotherms were fit with 
the following equation: 
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where K is the binding constant and C is the total surfactant concentration.  The values 
obtained for K are shown in Table 5.1 along with the surfactant charge ratio, R: 





R =                                                   (6) 
where A is the surfactant in excess and B is the oppositely charged surfactant.  Hence R 
is always greater than one and is a quantitative expression of the amplitude of excess 
negative or positive charge associated with a bilayer.  A related quantity reported in 
Table 5.1 is ∆C, which expresses the absolute excess charge concentration as the 
difference in concentration between [A] and [B] in Equation 6.  Table 5.1 also includes 
entries for the apparent encapsulation efficiencies, ε, which were reported previously 11 
but have been remeasured using a longer column to give more precise results (longer 
SEC column allows for greater separation of vesicle and free dye bands).  The ε values 
were calculated by measuring the fraction of dye in a 1 mM solution that eluted with the 
vesicle band during SEC.  It is referred to as the apparent encapsulation efficiency 
because it contains contributions from both encapsulated and adsorbed dyes.  K values, 
however, only represent dye adsorption to the vesicle exterior.  The good correspondence 
between ε and K confirms that bilayer adsorption is responsible for the efficient capture 
and sequestration of dye molecules by oppositely-charged vesicles.  The K values are 
also related to the binding free energy ∆G°: 




=                                                   (7) 
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Table 5.1. Association constants and encapsulation efficiencies for different vesicle/dye 
combinations. a. Surfactant mixtures were characterized by their CTAT-to-SDBS weight 
ratios (w/w). b. The charge ratio is determined from Equation 5.5.  c. The   values are the 
percentage of a 1 mM dye solution that elutes with vesicles during SEC.11 "n/a" refers to 
a value that cannot be obtained or is superfluous to the current study.  Saline and "dye 
outside" vesicle measurements are also shown here. 
 
For consistency with our previous studies, vesicle samples were initially prepared 
at two different surfactant compositions, 7:3 and 3:7 w/w CTAT to SDBS.  Vesicles with 
excess CTAT or SDBS are denoted as V+ and V–, respectively.  V+ refers to the excess 
positive charge on the vesicle bilayers when there is an excess of CTAT. In 7:3 w/w 
samples, the concentrations of CTAT and SDBS are 15.4 mM and 8.6 mM, respectively. 
This corresponds to 6.8 mM excess CTAT, which yields a 1.8 fold molar excess of 
cations, R = 1.8.  Likewise, V– refers to vesicles with a net negative charge.  In 3:7 w/w 
Negligible4141 ± 27.5 x 104CF7.81.86.5:3.5
CTAB-rich (V+)
n/an/a62 ± 77.5 x 104CF11.838:2




n/an/a56 ± 311 x 104R6G13.53.13:7











samples there is a 13.5 mM excess of SDBS (the samples contain 6.6 mM CTAT and 
20.1 mM SDBS), or a 3.1 fold molar excess of anions.   
 
To study electrostatic adsorption using FCS, oppositely charged probe molecules 
were used (see Figure 5.5).  For V- samples R6G was used and for V+ samples either 
SR101 or CF were used.  In Table 5.1 it can be seen that adsorption of R6G to V- samples 
is significantly stronger than for CF to CTAT-rich V+ samples and, to a lesser extent, for 




Figure 5.5. Adsorption isotherms obtained from FCS.  Each isotherm was fit to equation 
5 and the binding constant is given in Table 5.1.  For CTAT-rich vesicles (A) and (B) the 
points corresponding to 10, 20 and 30 µM were excluded in the fitting process as 
discussed in the text. 
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This may be attributed to the greater bilayer charge associated with V- samples; 
however, the increasing R values measured for R6G in V- samples does not induce a 
marked increase in K.  In comparing K values from the 4:6 and 7:3 samples, which have 
similar R values but opposite bilayer charges, there is a great difference in K that can not 
be accounted for by charge alone.  Previous work shows that in the case of V+ samples, 
there is very little difference between binding of SR101, net charge of -1, and CF, net 
charge of -3.  These observations suggest that charge stoichiometry is unimportant in 
determining bilayer adsorption.  Figure 5. shows binding curves collected from V- 
samples with different charge ratios.  The isotherms for the three samples are essentially 
indistinguishable.  Interestingly, preliminary results of apparent encapsulation efficiency 
do suggest a dependence on charge stoichiometry, with an increase in R from 1.8 to 3.0 
for CTAT-rich vesicles leading to nearly a fourfold increase in ε for the R=3.0 sample.  
Then again, CTAT-rich vesicles also showed unique behavior in FCS studies as the only 





Figure 5.6. Adsorption isotherms illustrating the effects of (A) bilayer charge 
stoichiometry and (B) excess counter ion identity. 
A plausible explanation to account for the relatively weaker adsorption of CTAT-
rich samples could be the lipophilicities of the counter ions.  In CTAT-rich samples the 
unpaired cetyltrimethylammonium (CTA+) is available to interact with tosylate ions 
(TOS-).  Bulky organic ions such as tosylate readily form ion pairs in water and this 
increases their hydrophobicity.  Adsorption to the bilayer interface of the CTAT-rich 
vesicles is extremely favorable for tosylate since the hydrophobic toluene moiety can 
intercalate into the bilayer leaflet while the sulfonate group forms an ion pair with CTA+.  
This arrangement is energetically favorable and hence is unlikely to be disrupted by the 
addition of other organic anions (i.e. binding large tosylates will block the vesicle surface 
from binding to probe molecules).  In SDBS-rich samples the excess DBS- only weakly 
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pairs with sodium residing in the Stern layer which is a much weaker interaction.  To test 
this we have substituted CTAT with CTAB and prepared CTAB-rich vesicles with a 
charge ratio of R = 1.8 for comparison with our 7:3 CTAT-to-SDBS samples.  For 
comparison with CTAT-rich samples, both K and ε were determined for CF binding to 
the CTAB-rich vesicle samples.  These values are reported in Table 5.1 and the binding 
isotherms for CF on both CTAT-rich and CTAB-rich vesicles are compared in Figure 
5.6B.  From the two curves, the average bound fraction of CF on CTAB-rich vesicle for 
each concentration is larger than CF on CTAT-rich vesicle.  Although the errors of bound 
fraction for several vesicle concentrations are overlapped, which can be introduced by the 
error from the vesicle preparation, the overall trend of the two curves confirms that the 
binding of CF on R=1.8 CTAB-rich vesicle is stronger than CF on R=1.8 CTAB-rich 
vesicle.  There are no reports of CTAB/SDBS vesicles in the literature, but from dynamic 
light scattering and SEC measurements vesicle do appear present for 6.5:3.5 w/w CTAB 
to SDBS (R=1.8) at 1% total surfactant.   
 
The results from the above study revealed that electrostatic forces play an 
important role in determining the encapsulation efficiency of surfactant vesicles. A 
common method for confirming and evaluating the role of electrostatic interactions in a 
binding process is to monitor the effect of salt concentration on binding.  When 
additional salt is added, electrostatic interactions between an ionic probe molecule and a 
charged surfactant bilayer is expected to be reduced due to the change in ionic strength of 
the solution.  The loading ability of the surfactant vesicles is expected to be diminished as 
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well.  Therefore understanding electrostatic interactions is critical to understanding the 
result of these experiments and the basic theory25 is introduced below.  
 
 The distribution of ionic molecules as counterions near a charged surface which 
could be a surfactant vesicle surface is described by the Boltzmann equation  














exp)( 0                                      (8) 
where in  is the concentration of ion i at a certain position x, 0in  is the concentration of 
ion i in the bulk, iz  is the valency of ion i , e is the charge of an electron and )(xΦ  is the  
electrostatic potential at position x. what is kb and T. 
 
 The electrostatic potential Φ  of a charged surface in a liquid medium is described 
by the Poisson equation, 





−=Φ∇                                                       (9) 
where *ρ  is the charge density, equal to ∑− iienz . 
 
 When considering a Boltzmann distribution of molecules near a charged surface, 
one can use the Poisson-Boltzmann distribution equation to describe the charge density of 
ionic molecules at distance x from the charged surface, 
                                                       
εε 0
2 ∑−=Φ∇ iienz   .                                               (10) 
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 Solving this equation gives an electrostatic potential: ( )xκ−Φ=Φ exp0 , where κ  
is the Debye-Huckel parameter with units of inverse length.  Another parameter is 
defined as 1−= κλD , which is called Debye length (See Figure 5.7.).  Dλ  in turn is 
related to another important parameter, ionic strength I and is found to be proportional to 
2
1−
I .  Ionic strength is defined as  
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 The Debye length for 1:1 electrolyte (e.g. NaCl ) in solution at a concentration C 
(mol/L) is:   




=λ                                                           (12)                                          
When C is 0.001, 0.01 and 0.1 M respectively, the corresponding Debye length Dλ  is 9.6, 
3.04, 0.96 nm respectively. 
 
 From above deduction, most counterions are held within the Debye length of the 
charged surface due to the electrostatic interaction.  Electrolyte valency and concentration 
determines the of the Debye length.  The binding of ionic molecules to a charged surface 
is reduced by addition of an electrolyte, sodium chloride in this study.   
 
Sodium chloride, a critical component making up the physiological environment, 
was utilized to explore this effect. These studies were undertaken as an important first 
step toward investigating the potential of surfactant vesicles as a drug delivery system.  
 
Bulk SEC measurements were made for CF encapsulated in CTAT-rich vesicles 
and for R6G in SDBS-rich vesicles. Both vesicles were made with normal saline solution 
instead of aqueous solution. The overlap of resulting DLS and UV-vis absorption are 
shown in the Figure 5.8.  CF encapsulation was seriously impacted (the encapsulation 
efficiency was dropped from 24% to 0%). On the contrary, encapsulation of R6G in 




Figure 5.8. SEC results from studies of dye binding and encapsulation in normal saline.  
(A) Apparent encapsulation of carboxyfluorescein drops from 24% to 0% under 
physiological salt concentrations.  (B)  Conversely, the apparent encapsulation of 
Rhodamine 6G is unchanged in normal saline. 
 FCS measurements of the binding efficiency of above systems also were 
conducted (see Figure 5.9.). The fraction of R6G bound to the SDBS-rich vesicles was 
not impacted at the salt concentration range from 10µM to 200mM. CTAT sample lost 
nearly all ability to sequester when 100mM sodium chloride was present in the solution. 
FCS results were consistent with bulk measurement since sodium chloride concentration 




Figure 5.9. FCS results from studies of dye adsorption as a function of salt concentration. 
The dots and squares are the fraction of CF bound to the CTAT-rich vesicles and R6G 
bound to SDBS-rich vesicles as the changes of concentration of sodium chloride, 
respectively. 
 
Salt studies in both bulk and FCS measurements revealed that electrostatic 
interactions were impacted by addition of sodium chloride. However, the effect of salt on 
different systems varies. The encapsulation depends on the nature of surfactant vesicles. 
In our study, SDBS-rich vesicles are less susceptible than CTAT-rich vesicles. Extra salts 
can displace CF from the bilayer easily due to the decreased interaction of CF with 
tosylate rich external layer of V+. By contrast, the interaction of R6G with the sodium 
rich external layer is very strong. The impact of salt is diminished in V-. Those results are 





 Our studies demonstrate the utility of fluorescence correlation spectroscopy as a 
means of studying binding of probe molecules to surfactant vesicles.  Electrostatic 
adsorption on the outside surface of the vesicle bilayer seems to predominate over dye 
that is truly “encapsulated” within the inner core of the vesicles, as observed by using 
size exclusion chromatography to compare dye sequestration and capture for vesicle 
mixtures with dye added before and after vesicle formation.  This adsorption 
phenomenon may be explained by models of charge segregation between the inner and 
outer leaflets of the vesicle bilayer, which suggest that excess charge resides mostly on 
the outer bilayer surface.  After all, excess charge at the outside vesicle surface makes 
electrostatic binding of oppositely charged dye to the outside surface very favorable.  
Binding isotherms constructed from FCS measurements yield a picture of free energy, 
and larger binding coefficients for the default 3:7 V- system (charge ratio R=3.0) than for 
the benchmark 7:3 V+ system (R=1.8) support the charge segregation concept.  While the 
higher binding coefficients and encapsulation efficiencies initially observed for V- 
systems appear to be due to counterion identity and excess charge, these systems do 
appear much more stable in saline (a necessity for drug delivery and any other biological 
application) than V- vesicles rich in either CTAT or CTAB, as indicated by 
measurements of ε in saline solutions for V+ and V- solutions.  Before prematurely 
declaring V- vesicles as innately superior encapsulation/adsorption vesicles, however, it 
would be wise to await further results of ε (not yet shown in Table 5.1) and to conduct 
FCS and SEC experiments with a cationic fluorescent dye other than R6G.  Such results, 
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taken into consideration with cell targeting and toxicity studies currently underway in 
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Chapter 6. Conclusions and Future Work 
 
 
6.1.  Conclusions 
 
Initial experiments conducted in this work revealed that charged surfactant 
vesicles, formed in mixtures of CTAT/SDBS/water, are extraordinarily efficient for 
sequestering charged organic molecules.  Vesicles only form when one surfactant is in 
excess and therefore the vesicle bilayer always possesses a charge, either negative or 
positive depending on the surfactant that is in excess.  High efficiency capture is 
observed when the cargo molecule has the opposite charge from the vesicle bilayer.   
Because these systems are equilibrium structures and are extremely stable, the release 
rate of captured solutes is very slow; hence preparations of surfactant vesicles with cargo 
molecules possess extremely long shelf-lives.  Among the probe molecules investigated, 
a drug molecule, Doxorubicin HCL (Dox), could be encapsulated with 55% efficiency in 
SDBS-rich (V-) vesicles.  This is in contrast with previous studies for the application of 
liposomes in drug delivery that showed lower capture and higher leakage rates.1  Given 
the extremely high capture efficiency and long-term stability, surfactant vesicles are 
promising candidates for use as drug delivery “vessels”. 
       
In addition to being  possible candidates for drug delivery, surfactant vesicles may 
also be promising new media for charge-based separations.  It was shown in previous 
chapters that electrostatic interactions play an important role in the high “apparent” 
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encapsulation efficiencies of surfactant vesicles.  By taking advantage of such strong 
interactions between charged surfactant bilayers and ionic molecules, we were able to 
show that surfactant vesicles can be used to separate oppositely charged molecules.  This 
was achieved by using a simple sephadex column to separate vesicles containing 
oppositely charged molecules (e.g. SDBS-rich vesicles containing the Rhodamine 6G 
cation) from free dye possessing the same charge sign as the vesicles (e.g. the 
carboxyfluorescein anion with SDBS-rich vesicles).  This separations method is efficient, 
easy and cheap relative to methods such as gel electrophoresis. 
 
The high encapsulation efficiency for surfactant vesicles is dependent on many 
factors and several have been investigated here.  The first one is the excess charge on the 
surfactant vesicle bilayer due to the different compositions of CTAT and SDBS.  In 
Chapter 5, Table 5.1, different excess charge concentrations (∆C (mM)) lead to different 
“apparent” encapsulation efficiencies of dyes at various CTAT/SDBS ratios.  As ∆C 
increases so does the encapsulation for ionic dye molecules in CTAT/SDBS system.   
This is simply due to the increasing number of available binding sites for electrostatic 
adsorption. 
  
The second important factor investigated is the counter ion identity which was 
found to impact encapsulation efficiency.  In CTAT-rich vesicles the tosylate ion 
occupies the potential electrostatic binding sites represented by the excess CTAT 
molecules and in SDBS-rich vesicles the excess counterion is the sodium ion.  CTAT-
rich vesicles have a lower encapsulation efficiency than SDBS-rich (V-) vesicles.  Even 
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when one considers excess charge, V- still encapsulates more oppositely-charged 
molecules.  It is hypothesized that this is due to the amphiphilic tosylate counterion being 
more stable and less likely to be replaced at the bilayer binding sites represented by the 
CTA+ surfactant.  The counterion of DBS-, is the water soluble sodium ion and interacts 
weakly with the bilayers and therefore is easily replaced by a positively charged 
amphiphilic probe molecule such as Rhodamine 6G or doxorubicin.   A similar trend was 
observed for vesicles formed from CTAB, in which improved efficiency was observed 
relative to CTAT-rich vesicles. 
 
A final important issue that impacts all electrostatic interactions is that of ionic 
strength.  Additional salts in solution can reduce the Debye screening length between 
charges in aqueous solution, and therefore between unpaired surfactants in the vesicle 
bilayer and oppositely charged molecules in solution.  This effect leads to less binding or 
encapsulation when surfactant vesicles are exposed to high salt concentration. The 
consequence for adding salt to V+ or V- systems varies.  Unlike V+ samples, 
encapsulation by V- samples remains high at salt concentrations above physiological 
conditions up to tens of millimolar sodium chloride.  This finding suggests that V- 
samples are promising for drug delivery or cellular diagnostics in buffers with high ionic 
strength.  
 
Under conditions where high apparent encapsulation efficiency is observed most 
ionic molecules are believed to be adsorbed on the exterior of the surfactant vesicle 
bilayer.  This has been investigated and quantified by comparing SEC results of vesicles 
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formed in the presence of dye solution with SEC results when dye molecules are added 
after the vesicles formed.  As discussed in Chapters 1 and 5, the asymmetric distribution 
of unpaired charged surfactant between the outer and inner bilayer accounts for the fact 
that vesicle loading does not depend very much on whether dye is added before or after 
vesicle formation.  The observation that dye molecules bind strongly to the outer 
membrane is consistent with more unpaired charges on the outer layer compared to the 
inner layer of the bilayer and this agrees with theoretical models suggesting that nonideal 
mixing in the bilayer is crucial for spontaneous bilayer curvature.  
 
FCS has been successfully introduced to quantitatively explore the strong 
electrostatic interaction between charged dye molecules and oppositely charged 
surfactant bilayers.  FCS allows one to conduct binding measurements at very low sample 
concentration (10-9-10-8 M).  This technique was successfully used to obtain binding 
isotherms for vesicles interacting with low concentrations of probe molecules.  Results 
from FCS studies were consistent with bulk SEC measurements in that higher binding 
constants correlated with higher encapsulation.  It was found that both bilayer 
composition and counter ion identity can strongly affect the apparent encapsulation 
efficiency; hence FCS can provide quantitative data about electrostatic interactions 
between surfactant vesicles and charged solutes.  
 
6.2.  Future Work 
 
The use of surfactant vesicles as drug carriers should be investigated by studying 
the vesicles under physiological conditions and determining the effects of the vesicles on 
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biological systems and vice versa.  For example, it is important to determine the stability 
and encapsulation efficiency of these vesicles when exposed to differing environments, 
such as high or low pH and varying salt concentrations.  
 
In order for surfactant vesicles to be of therapeutic use, the cytotoxicity of the 
vesicles must be investigated.  Kuo et al. have shown that catanionic vesicles composed 
of the surfactants HTMAB and SDS are nontoxic towards mouse fibroblast and liver 
cells.2  Work is currently being done on the CTAT/SDBS system in conjunction with Dr. 
John Fisher’s lab in the Department of Bioengineering to measure the cytotoxicity of the 
vesicles.  Initial results show that V
- 
vesicles are nontoxic toward chondrocytes at 
concentrations up to 0.1 µg/ml total surfactant. 
 
To date, many surfactant vesicle systems have been discovered.  This can lead to 
finding other intriguing systems with high encapsulation and slow release rates is an 
important goal.  For example, CTAB/SDBS system has been initially explored in Dr. 
English’s lab for the encapsulation ability and long term stability and the work will 
continue in the future. 
 
 Recently, a study showed that surfactant vesicle was encapsulated by chitosan and 
co-electrodeposted on a charged surface such as a microfabricated wafer in solution.3  By 
control localized electrical stimulations, the solubility of chitosan film was impacted. 
Hence, surfactant vesicle entrapped within chitosan was mobilized.  This approach can be 
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potentially used in controllable means, such as varying electronic signal, pH, to store and 
release vesicle-based reagents/therapeutics for microfluidic/medical applications. 
 
There is still a great deal of work to be done concerning surfactant vesicles and 
their potential use as drug delivery agents, but the present research has shown that they 
are remarkably efficient at entrapping solutes—a fact that could be of great importance 
for developing drug carrier technology.  One shouldn’t forget that there are other possible 
applications of these vesicles as well, in such areas as cosmetics and agrochemicals.  
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A.1. Data and Images from SEC Experiments for Evaluation of 
 Apparent Encapsulation Efficiency (ε ) 
 
The four figures below are counterparts to Figure 4.2. of the Chapter 4 with 
photographs, DLS intensity (solid line), and UV-vis absorbance data (dotted line), for 
each of the solutes studied.  The encapsulation values for each solute are reported in 































Figure A.1. DLS and encapsulation efficiency study through SEC for dye molecules of 




A.2. Separations Performed on a Mixture of LY and Dox 
 
 
 In addition to using catanionic vesicles to separate the dyes CF and R6G, we also 
conducted separation experiments using the anionic dye, LY and the cationic drug, Dox.  
The separation illustrated below was performed on an equimolar solution of the two dyes.  
The total dye concentration was 1 mM.  We again observed very efficient separation 
using vesicles, much like in Figure 4 of the main paper. The figure below shows the DLS 
intensity (solid line) and UV-vis absorbance of LY (dashed line) and Dox (dotted line) 
for each eluted fraction.  The vesicle band for the V+ sample contained 30% of the LY 
with no detectable Dox, while the vesicle band for the V- sample contained 63% of the 
Dox with no detectable LY.(See in Figure A..) 
 







B.1.  Diffusion coefficient for micelles is lower than for free dye and higher than for 
vesicles. In fact, it happens to be right in-between.  That also follows our prediction since 
micelles are larger than individual molecules but much smaller than the vesicles.  No 
very slow component was seen, so there are either no huge SDBS aggregates or if there 
are any dye does not bind to them.  Therefore, the data looks like it allows us to conclude 
that the slow component we see in the SDBS-rich samples is due to SDBS-CTAT 
structures, presumably vesicles. (See Figure B.) 
 
Figure B.3. Square, circle, and cross represents autocorrelation curve of vesicle, SDBS 
micelle, and free dye, respectively. Corresponding diffusion coefficient (cm2.s-1) is 
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